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The onset of puberty and sexual development as well as normal reproductive function are 
dependent on pulsatile secretion of gonadotropin releasing hormone (GnRH). GnRH is 
secreted from the GnRH neuron nerve terminals in the hypothalamic median eminence into 
the portal vessels that lead to the anterior pituitary. The pulsatile secretion of GnRH stimulates 
the release of gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone 
(FSH), which, in turn, regulate various gonadal functions. In rare occasions, the onset of 
puberty is delayed or completely absent. This can be caused by disrupted development, 
migration, or function of GnRH neurons, resulting in defects in sexual development and 
infertility. Congenital GnRH deficiency is termed congenital hypogonadotropic hypogonadism 
(CHH), and CHH combined with hyposmia or anosmia (reduced or absent sense of smell) is 
known as Kallmann syndrome (KS). CHH and KS are genetically heterogeneous diseases, 
with over 30 genes reported in association with KS and CHH to date. How mutations in these 
genes cause GnRH deficiency is not yet comprehensively understood, but several are 
postulated to affect GnRH neuron development.
Human pluripotent stem cells (hPSCs) are the equivalent of undifferentiated cells in the early 
embryo, and able to give rise to all tissues and cell types in the human body. Thus, hPSCs 
have become a widely used tool for studying the differentiation of specialized cell types and 
the causes for human diseases in vitro.
Developing methods for directed differentiation of hPSCs into GnRH neurons requires insight 
into the events which lead to the specification of GnRH neurons during embryonic 
development. GnRH neurons are born in the olfactory placodes in the nasal area of the 
developing embryo. After their delamination from the olfactory neuroepithelium, the 
differentiated postmitotic GnRH neurons take an upward migratory route along the axon fibers 
of the terminal nerve around the olfactory bulb, cross the cribriform plate to the forebrain, and
finally make a ventral turn into to the preoptic area of the hypothalamus. The exact cell type 
within the olfactory placodes that gives rise to GnRH neurons is not entirely known. Its 
precursors have been proposed to be of both preplacodal ectoderm and neural crest origin. 
The aim of this work was to create a model in which to study the molecular mechanism of 
GnRH neuron differentiation and the mechanisms of CHH-associated genetic mutations on 
GnRH neurogenesis in humans. The literature review of this thesis addresses the relevant 
background in the field of GnRH neuron development; from neural crest and preplacodal 
development at gastrulation stages, to ontogeny, migration, and maturation of GnRH neurons 
at puberty. This thesis presents experimental validation of the methods for in vitro generation 
of GnRH neurons from human pluripotent stem cells, and the findings include the discovery of 
several genes and proteins expressed during GnRH neuron differentiation.
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ABBREVIATIONS
AMH = anti-Müllerian hormone
APC = adenomatous polyposis coli (gene)
ARN = arcuate nucleus
BIO = 6-bromoindirubin-3'-oxime, GSK3 inhibitor
BMP = bone morphogenetic protein
CDGP = constitutional delay of growth and puberty
CHARGE = coloboma, heart defects, atresia choanae, growth retardation, genital abnormalities, and 
ear abnormalities
CHH = congenital hypogonadotropic hypogonadism
ChIP = chromosome immunoprecipitation
CNS = central nervous system
CRISPR = clustered regularly interspaced short palindromic repeats
CS = Carnegie stage, human embryo development
DAPT = N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester
DCC = Deleted in colorectal cancer (gene), Netrin-1 receptor
DKK1 = Dickkopf WNT signaling pathway inhibitor 1
DM = Dorsomorphin
DISCO = 3D imaging of solvent-cleared organs
DCX = Doublecortin
ECC = embryonic carcinoma cell
EDTA = ethylenediamine tetraacetic acid
E (nn) = embryonic days, mouse development
EMT = epithelial-to-mesenchymal transition
ESC = embryonic stem cell
FACS = fluorescence-activated cell sorting
FBS = fetal bovine serum
FGF = fibroblast growth factor
FSH = follicle-stimulating hormone
GnRH = gonadotropin-releasing hormone
GSIs = gamma-secretase inhibitors
GSK3-β = glycogen synthase kinase 3β
GW = gestational week (of pregnancy)
hCG = human chorionic gonadotropin
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HGF = hepatocyte growth factor
HPG = hypothalamus-pituitary-gonad (axis)
hPSC = human pluripotent stem cell
iPSC = induced pluripotent stem cell
IVF= in vitro fertilization
KEGG = Kyoto encyclopedia of genes and genomes
KS = Kallmann syndrome
LH = luteinizing hormone
LIM = Lin11/Isl1/Mec3 domain proteins
mESC= mouse embryonic stem cell
NC = neural crest
NICD = Notch intracellular domain
OE = olfactory epithelium
OP = olfactory placode
ORN = olfactory receptor neuron 
PBS = phosphate buffered saline
PCR = polymerase chain reaction
PFA = paraformaldehyde
pNCC = premigratory neural crest cells
qPCR = quantitative real-time polymerase chain reaction
RE = respiratory epithelium
ROCK = rho-associated protein kinase
RP3V = rostral periventricular nucleus of the third ventricle
SDF1 = stromal cell-derived factor 1
TGF-β = transforming growth factor β
TN = terminal nerve
VNO = vomeronasal organ
Wnt = wingless-related integration site
WT = wild type
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INTRODUCTION
Embryonic GnRH neurons were first described as a postmitotic, migratory group of cells
travelling from the olfactory placodes towards the forebrain (Wray, Grant & Gainer, 1989a, 
Wray et al., 1994). Their precursors are thought to arise in the neuroepithelium of the 
developing olfactory organ in the developing face. We still to this day do not know the previous 
events leading up to the delamination of postmitotic GnRH neurons from the neuroepithelium, 
and no definitive, selective GnRH neuron progenitor markers have been discovered. 
Therefore, the precursor subtype that gives rise to GnRH neurons has never been precisely 
defined. Several theories of their origin and development have emerged in a few models of 
different animal species. 
A stem cell has a capacity to give rise to new, more specialized cells, or self-renew, and retain 
differentiation potential. Their fate depends on the time and place, the signals received from 
the environment, and intrinsic genetic and epigenetic mechanisms, leading to combinations of 
signal interpretations inside the cells. Therefore, when kept in appropriate culture conditions,
pluripotent stem cells retain the potential to differentiate into any specialized cell type. This 
feature can be utilized in research, for modelling development and disease of specialised 
tissues. 
REVIEW OF THE LITERATURE
1. Human pluripotent stem cells as a research tool
Blastocyst stage embryos
The human embryo reaches the blastocyst stage in five to six days after fertilization. At this 
stage the embryo is a ball-shaped hollow cellular structure with a single layer of outer cells 
(trophectoderm) and a small cluster of inner cell mass (ICM) cells inside the fluid filled sphere. 
Further in the development, the outer trophectodermal cells contribute only to extraembryonic 
tissues such as placenta, while ICM cells are pluripotent and serve as starting material for the 
entire embryo. As development proceeds to gastrulation the ICM goes on to form three germ 
layers, which give rise to all the tissues and organs in the body (Hill, 2020) (Figure 1 A).
Embryonic stem cells in vitro
The derivation of pluripotent stem cells into laboratory culture was inspired by studies of 
teratomas in the 1950s. Teratomas are extraordinary tumors that can contain different types 
of tissue, such as hair, teeth, and bone. These tumors are otherwise rare but were found to 
be more common in a specific inbred mouse strain, ‘129’ (Stevens, Little, 1954). The tumor 
cells from the 129 mouse line could be easily grown and expanded in vitro as immortal cell 
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lines, called embryonic carcinoma cells (ECCs) (Kleinsmith, Pierce, 1964). The ECCs were 
undifferentiated in vitro, and when transplanted into new mice, they would give rise to new 
teratomas. These findings led to further interest toward potential methods to capture cells from 
an early stage embryo to utilize their innate embryonic properties of pluripotency also in vitro.
In 1981, Gail R. Martin described the isolation of mouse blastocyst ICM cells and their 
subsequent culture in vitro as mouse embryonic stem cells (mESC). The cells were maintained 
and expanded in culture as pluripotent stem cell colonies and like ECCs, the undifferentiated 
mESC were capable of giving rise to teratomas when transplanted into extrauterine tissues. 
The term ‘embryonic stem cell’ was thus introduced for the first time, and the authors made 
certain predictions into the future of this scientific field; “Given these results, it seems likely 
that there will soon be available pluripotent, embryo-derived cell lines with specific genetic 
alterations that should make possible a variety of new approaches to the study of early 
mammalian development” (Martin, 1981).
After injection into blastocyst embryos mouse ECS were able to contribute to multiple adult 
tissues of chimeric mice (Bradley et al., 1984), which thereby became a golden standard test 
for assessing stem cell pluripotency. In the 1990’s, research proceeded into primate 
embryonic stem cells, which further confirmed and generalized the ability of ESCs to retain 
their pluripotency during in vitro cultures (Thomson et al., 1995).
Targeted gene editing of mouse ES cells, and transfer to the inner cell mass to create a mosaic 
embryo, was first shown by Schwartzberg and colleagues, who reported germline 
transmission of the genetic mutation in the mice chimeras by homologous recombination 
(Smithies et al., 1985, Capecchi, 1989, Schwartzberg, Goff & Robertson, 1989). Mario 
Capecchi, Sir Martin J. Evans, and Oliver Smithies were awarded the Nobel Prize in 
Physiology or Medicine 2007 because of their research in the principles of homologous 
recombination, which made it possible to produce mice with modified genomes using ES cells. 
These advances played a key role for researcher’s ability to study the function of genes, and 
to model genetic diseases in mice. Since then, new genome editing techniques have emerged, 
up to the latest discovery of CRISPR-Cas9 gene editing-based on the defense system of 
bacteria against viruses, allowing for faster, cheaper, efficient, and precise gene editing, also 
in human pluripotent stem cells (Ran et al., 2013).
Human embryonic stem cells and induced pluripotent stem cells
In 1998, the first human pluripotent stem cells were isolated and cultured from blastocyst 
embryos donated from a fertility clinic. The cell lines described in this report would later 
become the source of the most widely used human embryonic stem cell lines grown in vitro
(Thomson et al., 1998).
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A new significant break-through in the field of pluripotent stem cells took place in 2006, when 
the first induced pluripotent stem (iPS) cells were generated from mouse fibroblast cells 
(Takahashi, Kazutoshi, Yamanaka, 2006). It was found that by the ectopic expression of only 
four factors, Oct3/4, Sox2, Klf-4, and c-Myc, the somatic cells could be reprogrammed into a 
stem cell stage and thus reverted back to pluripotency. The cells were consequently capable 
of teratoma formation, and they contributed to a chimeric fetus after injection into blastocyst 
embryos. Not long after, the same team succeeded also in the generation of human iPS 
(hiPSC) cells from skin fibroblasts (Takahashi, K. et al., 2007). This allows the use of patient-
specific stem cells to study diseases, and potentially develop new treatments. Today hiPSCs 
are widely used to model the molecular mechanisms of disease-associated genetic mutations, 
by differentiation of hiPSCs to specific cell types of interest. Also, hiPSCs have potential for 
future use in regenerative medicine and tissue replacement therapy. With current genome 
editing tools, a patient’s genetic mutation can be corrected in hiPSCs (Gravesteijn et al., 2020).
In the future, this could be used to create autologous tissue replacements from the patient’s 
own cells, to overcome immune rejection that can arise in organ transplantations.
Development of culture conditions and differentiation techniques
After the discovery of hESCs and hIPSCs, the cells were typically cultured on mouse, or later 
human, fibroblast feeder cells (Hovatta et al., 2003), and cell culture media contained fetal 
bovine serum (Eguizabal et al., 2019). This was later found to be a cause of variability between 
experiments. In order to develop more defined culture conditions that reduce the risk of 
infection during potential clinical use, a few important steps were taken; I) by moving to feeder-
free cultures, II) the use of serum free media and, III) animal free (xenofree) products (Ludwig 
et al., 2006, Chen et al., 2011, Nakagawa et al., 2014). Gradual improvements to culture
conditions has thus allowed for a new field in stem cell research; the directed differentiation 
into specialized human cell types in vitro. For example, the reporting of BMP pathway inhibition 
using small molecules during neuronal lineage differentiation has greatly improved 
differentiation efficiencies from human pluripotent stem cells to neurons (Chambers et al., 
2009).
The future for hPSCs now lies in creating new innovative treatments and personalized 
medicine based on what we have learned from stem cell research during the last decades. 
Progress in the field of biotechnology has led to development of microfluidic devises that can 
be integrated with cells in 3D culture, referred to as ‘organ-on-chip’ technology. This
technology allows mimicking of tissue environments and physiological characteristics on a 
micro-scale in vitro. This way we can limit the need for animal models, simultaneously allowing 
for personalized disease modelling in human-specific settings (Kimura, Sakai & Fujii, 2018).
In the field of neuroscience, brain organoids or so called ‘mini brains’ are 3D cultures 
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generated from hPSC-derived neuronal cells. Brain organoids are cell aggregates that 
integrate several cell types and can be used to study aspects such as neuronal connections, 
electrical activity, and cell patterning, which holds great potential for modelling 
neuropsychological disorders, epilepsy, stroke etc. in a patient-specific context (Marton, 
Pasca, 2019).
Directing neuronal differentiation
The events leading to development of the embryonic nervous system (Figure 1 A) are 
essentially similar in all vertebrates, and have been extensively studied in amphibian and avian 
embryos since the early 1900s. In the 1920’s, Hilde Mangold and Hans Spemann introduced 
the term ‘embryonic induction’, describing how the development of neural ectoderm of an 
amphibian embryo becomes induced, by a cluster of cells referred to as the ‘organizer’
((Spemann, Mangold, 2001) (Orig. publ. 1923)). Later, the two Finnish researchers Lauri 
Saxén and Sulo Toivonen made important contributions to the field of embryology by 
presenting the two-gradient hypothesis for induction of the nervous system. Their model 
described the requirement of gradients of two opposing chemical signals, derived from nearby 
tissues, to induce and pattern the structures of the nervous system (Saxén, Toivonen, 1961).
Today we know that induction is achieved by secreted signalling molecules, which form 
morphogen gradients that instruct and pattern the tissue as it develops. During late 
gastrulation, the primitive node and the notochordal process act as the primary inductors of 
the nervous system (Figure 1 A). The primitive node forms from cells at the tip of the primitive 
streak, and during primitive streak elongation, a transient tissue condensation forms the 
notochord at the axial midline. The notochord induces neural plate formation in the overlying 
ectoderm by expression of signalling molecules noggin and chordin. The induction and 
patterning of the developing nervous system is thus achieved by the activation and repression 
of the main inductive signalling pathways, BMP (bone morphogenic protein), FGF (fibroblast 
growth factor), SHH (sonic hedgehog), and Wnt (Figure 1 B). The signalling molecules and 
their receptors, in turn, activate or inhibit the expression of cell type-specific transcription 
factors that regulate the determination and specification of a cell, from a multipotent progenitor, 
to a lineage-restricted cell type (Carlson, 2019).
Bone morphogenic proteins (BMPs) are secreted peptide hormones that induce growth of 
bone (osteogenesis), as the name implies. In surface ectoderm of the gastrula embryo, BMP 
signalling induces the specification of the epidermis. This also means that it is necessary to 
locally repress BMP in the neural plate for the neuroectoderm to form. Neural induction is 
achieved by secreted proteins that bind to and antagonize the effect of BMP signalling, such
as noggin, chordin and follistatin (Hawley et al., 1995, Fainsod et al., 1997, McMahon et al., 
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1998). Neuralization of the surface ectoderm is thus the in essence the ‘default state’, unless 
epidermis becomes induced by BMP (Hemmati-Brivanlou, Melton, 1997).
For directing neuronal specification from pluripotent stem cells in vitro, Noggin has been found 
to be sufficient for neuronal conversion. This was first reported using embryoid body (EB)-
based neuronal differentiation method (Elkabetz et al., 2008). The small molecule inhibitor
SB43152 was later reported to be stable and efficient in neural conversion of pluripotent stem 
cells (Smith et al., 2008). Small molecule SB43152 antagonizes Activin/Nodal signalling 
through the Nodal receptor. Nodal is a member of TGFβ superfamily, and like BMP, it 
represses neuronal cell fates.
A more efficient and reproducible means of neuronal specification was enabled by the
combination of dual SMAD inhibition and feeder-free monolayer culture (Chambers et al., 
2009) (Figure 1 C). Synergistic inhibition of endogenous SMAD signalling by noggin and
SB43152 in stem cells plated in high density 1) efficiently suppressed BMP signalling in order 
to repress pluripotency and trophoblast cell type differentiation and 2) directed differentiation 
toward neurectoderm expressing neuronal stem cell markers SOX1 and PAX6. The 
advantages of this method include low levels of neural crest or mesodermal differentiation, 
and thus, higher specificity is achieved. High cell density in the monolayer cultures also led to
a higher overall number of neuronal stem cells than previously reported (Chambers et al., 
2009). This robust method of dual SMAD inhibition has become the basis for multiple 
differentiation protocols towards specialized neuronal subtypes.
After the neural tube has developed, the neuronal stem cells need patterning to acquire 
regional subtype identities. In the developing brain, the establishment of the apical-caudal, 
dorsal-ventral, and medial-lateral axes are dependent on locally secreted growth factors; SHH,
retinoic acid, FGFs, and Wnt family proteins. In the human foetal brain, transcription factor 
profiles differ between brain regions, and these regionally specific combinations of markers 
can be used to monitor the regionalization of neuronal progenitors in vitro. Regional 
specification is important in order to be able to efficiently and reliably produce selected cell 
types (Tao, Zhang, 2016). Advances in regional subtype patterning in vitro have relied on 
clues gathered from classical developmental biology experiments as well as rare human 






Figure 1. Signalling pathways directing neural induction in vivo and in vitro.
A) Embryonic development from a blastula to neuronal induction in late gastrula stages. The inner cell mass (ICM) 
of the blastula-stage embryo contains pluripotent cells that will give rise to all the embryonic tissues. In the 
gastrulation-stage embryo, the three germ layers are formed by convergent-extension movement of cells through 
and around the primitive streak, forming embryonic mesoderm, endoderm, and ectoderm. Gastrulation also leads 
to formation of transient signalling centers that are important for neural induction. The primitive node, (an 
accumulation of cells at the anterior tip of the primitive streak, also called ‘Hensen’s node’), the prechordal plate, 
(mesoderm anterior to the notochord, also called the ‘head organizer’), and the notochord, function as sources for 
the signalling molecules that induce central neural system development. BMP inhibitors Noggin and Chordin, 
secreted from the primitive node and the notochord, are important neuronal inducers (Carlson, 2019). B) Simplified 
summary of the major growth factor signalling pathways that are responsible for the differentiation and patterning 
of cells and tissues during development. C) Directed neuronal induction from human pluripotent stem cell in vitro
by inhibition the TGF-β, Activin/Nodal and BMP signalling pathways. Image adapted based on (Borooah et al., 
2013, Chambers et al., 2009). D = dorsal, V= ventral, A = anterior, P = posterior.
2. The human reproductive axis
Hormonal regulation of puberty and fertility
GnRH neurons are essential regulators of reproduction and a part of the hypothalamic-
pituitary-gonadal axis. The onset of puberty and sexual development rely on pulsatile secretion 
of GnRH from the nerve terminals of the hypothalamic medial eminence into the portal vessels 
leading to the anterior pituitary. GnRH secretion stimulates endocrine release of luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH) form pituitary gonadotropes, which leads 
to increased secretion of the gonadal hormones, testosterone, and estrogen (Charlton, 2008).
The GnRH signal is received through the G-protein-coupled receptor (GnRH-R) in pituitary 
gonadotropes, and LH and FSH is released into systemic circulation. LH stimulates 
testosterone release from Leydig cells in the testes in males, which, in turn, stimulates growth 
and development of the secondary sexual characteristics (Nassar, Raudales & Leslie, 2019).
In females, FSH promotes follicular maturation in the ovary, and theca cells in the follicles 
respond to LH by secretion of testosterone, which is converted into estrogen via aromatase 
from the FSH-responsive granula cells. During the follicular phase of the menstrual cycle, FSH 
stimulates a gradual rise in estrogen, and when a critical level is reached, a rise in LH release 
is stimulated. This is refreed to as the ‘LH surge’ which triggers ovulation. LH stimulates the 
release of progesterone from the corpus luteum during the luteal phase of the menstrual cycle. 
Progresterone together with estrogen stimulates the endometrium to prepare for embryo 
implantation. Negative feedback from estrogen, as well as inhibin from corpus luteum,
downregulates FSH during the luteal phase. Progesterone is stimulated by human chorionic 
gonadotropin if pregnancy occurs, and if not, the corpus luteum will degrade and allow for a 
new cycle to begin, by stimulation of GnRH, and FSH (Rosner, Samardzic & Sarao, 2019).
The HPG axis is briefly activated during foetal development, and again during the first 3-6
months after birth, which is referred to as minipuberty (Lanciotti et al., 2018, Waldhauser et 
al., 1981). At birth, the drastic decrease in placental hormones leads to the reduction of the 
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negative feedback loop that regulates GnRH secretion. Therefore, gonadotropin and sex 
steroid levels begin to increase during the first 6-10 days after birth (Schmidt, Schwarz, 2000).
Minipuberty is thought to be essential for the development of the genital organs and fertility.
The HPG axis then remains relatively quiescent until puberty onset (Lanciotti et al., 2018).
Regulation of GnRH secretion in the hypothalamus 
At puberty, the frequency and amplitude of GnRH secretion increase. This pulsatility is a 
crucial feature that allows for activation of gonadotrope stimulation as a response (Belchetz et 
al., 1978, Wildt et al., 1981). GnRH neurons are able to synchronize their electrical activity 
and generate an episodic pattern of hormone secretion (Herbison, 2018).
GnRH neurons send single neuronal projections into the median eminence from the cell 
bodies in the hypothalamus. In contrast to classical axonal or dendritic properties, these single
projections have both axonal and dendritic properties; they can receive and integrate synaptic 
inputs, in addition to containing a spike initiation site that triggers action potentials, thereby
termed ‘dendrons’ (Herde et al., 2013). The GnRH neuron dendrons become densely
concentrated just outside median eminence, where dendrons split into short nerve terminals
that innervate the median eminence. The dense concentration of dendrons in this area 
suggests that synaptic input to dendrons, and dendron intercommunication outside the median 
eminences, may be involved in synchronizing GnRH neuron activity to form pulses (Herbison, 
2018, Moore et al., 2018).
Kisspeptin is a potent activator of GnRH neurons in the hypothalamus and crucial for normal 
puberty development (de Roux et al., 2003, Seminara et al., 2003). The Kisspeptin receptor 
(KISS1R, formerly known as GPR54) is expressed in GnRH neurons. Kisspeptin signalling 
induces depolarization of GnRH neurons, and responsiveness to Kisspeptin is increased 
before puberty onset (Han et al., 2005, Leon et al., 2016, Herbison, 2018). Kisspeptin is 
secreted by neurons located in the arcuate nucleus (ARN) in the mediobasal hypothalamus, 
and the rostral periventricular nucleus of the third ventricle (RP3V). The ARN Kisspeptin
neurons also secrete Neurokinin B and Dynorphin A, and are referred to as KNDy neurons
(Yip et al., 2015). These peptides are suggested to autoregulate the secretion of Kisspeptin 
by autosynaptically conveying stimulatory (Neurokinin B) and inhibitory (Dynorphin) signals
that lead to synchronized Kisspeptin neuron activity (Navarro, 2012, Lehman, Coolen & 
Goodman, 2010). The ARN Kisspeptin neurons have been denoted as the “pulse generators” 
of GnRH secretion, as they exhibit synchronized calcium activity episodes that coincide with 
LH pulsatility (Clarkson et al., 2017). GnRH neuron projections are present in the ARN and 
exhibit contact with KNDy neurons, as well as in the areas proximal to the median eminences. 
Furthermore, complex interconnections have been observed between the GnRH neurons, the 
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ARN, and the RP3V Kisspeptin neurons, and feedback mechanisms relay upstream input from 
local and periferal cues (Yip et al., 2015, Moore, Coolen & Lehman, 2019). Indeed, metabolic 
signals, chronic malnutrition, stress, and reproductive diseases, for instance, are known to 
suppress the secretion of GnRH (Tsutsumi, Webster, 2009).
3. Puberty
The neurobiological aspect of puberty initiation can be characterized as an increase in 
frequency and amplitude of GnRH secretion. Evidence suggests that this occurs as a result of 
lifted repression by neurobiological and epigenetic factors that have been set in place during 
the quiescent period of adolescence (Livadas, Chrousos, 2019, Heras et al., 2019). The timing 
of puberty is variable and influenced by genetic and epigenetic mechanisms, nutritional state, 
adipose tissue, environmental factors such as chemicals that are endocrine disruptors, as well 
as psychological stress (Parent et al., 2003, Sisk, Foster, 2004, Gajdos et al., 2010, Messina 
et al., 2016). A high number of genes are associated with the timing of puberty onset, and,
therefore, it is difficult to pinpoint the exact function of these genes (Perry et al., 2014, Day et 
al., 2017). The collective hypothesis is that the state of the body is relayed by an “intrinsic 
developmental clock” consisting of signals that can convey the stage of sufficient 
(neurobiological) maturation, growth, and metabolic status, before puberty is initiated 
(Herbison, 2016).
Congenital Hypogonadotropic Hypogonadism and Kallmann Syndrome
Disrupted development, migration, or function of GnRH neurons lead to defects in 
reproduction and sexual development. Rare genetic diseases that cause GnRH deficiency 
and lead to absent puberty and infertility are termed congenital hypogonadotropic 
hypogonadism (CHH). CHH combined with hyposmia or anosmia (reduced or absent sense 
of smell) is known as Kallmann syndrome (KS) and draws a link between GnRH neuron 
development and the olfactory system. CHH and KS are genetically heterogeneous 
developmental disorders, and KS accounts for around 50% of CHH cases. To date, over 30 
CHH-associated genes have been identified (Boehm et al., 2015, Young et al., 2019). The 
mutations associated with CHH and their molecular mechanisms are not yet comprehensively 
characterized but several of these genes are postulated to affect GnRH neuron development, 
migration, or function.
Foetal development of the HPG axis
During human foetal development, GnRH neurons arise at gestational week (GW) 5, and 
pituitary LH is detectable during GW 9. Human chorionic gonadotropin (hCG) is provided by 
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the placenta during the first trimester. The exact timing when pituitary gonadotropes become 
under hypothalamic control is not known, but foetuses lacking a hypothalamus due to 
anencephaly show normal development of pituitary up to GW 17 or 18, and CHH patients have 
normally differentiated genitalia. Pituitary LH levels first peak at midgestation and decrease 
near term, which is likely due to the increase in placental estrogen and progesterone, gonadal 
feedback, and maturation of gonadotropes by acquisition of relevant cell surface receptors 
(Young et al., 2019).
In male foetuses, the gonadal organ differentiation into testicles starts at GW 5-7. Sex 
determination is initiated by the SRY gene from the Y-chromosome, and is followed by sex 
differentiation in the bipotential gonads, derived from intermediate mesoderm in the early 
embryo. Sex differentiation leads to specification of the Sertoli and Leydig cells, followed by 
development of the external genitalia which is driven by testosterone. The foetal Leydig cells 
synthesize testosterone, which stabilizes the Wolffian (male urogenital) structures. Sertoli cells 
produce anti-Müllerian hormone (AMH), which has an important role in regression of the 
source for the reproductive tissues in the female, the Müllerian ducts (Makela et al., 2019).
GnRH-driven LH from the pituitary is needed for normal penile growth and testicular decent 
during the third gestational period. CHH patients have higher prevalence of micropenis and 
cryptorchidism (Bouvattier et al., 2011).
In female foetuses, the ovary develops in the absence of Y-chromosome, and the fallopian 
tubes, uterus and vagina start to form in the Müllerian ducts in the absence of AMH and
testosterone. Furthermore, local signals including sutained expression of Wnt-4 is required for 
repression of Leydig cell development and maintencance of female germ line cells (Vainio et 
al., 1999). Primoridal foetal ovarian follicles develop during GW 15 independent of 
gonadotropin. Estrogen is produced at this stage by the placenta and foetal ovaries have low 
levels of hormone production (Kurilo, 1981).
Minipuberty
Postnatal activation of GnRH secretion is initiated after the decline in placental-derived 
estrogen levels during the first weeks after birth (Waldhauser et al., 1981). In boys this leads 
to a peak in testosterone levels during 1-3 months of age, stimulation of Inhibin B in the Sertoli 
cells of the testis, and increase in testicular volume. The Sertoli cell population increases 
during minipuberty, which is critical for normal sperm production in adulthood. 
Spermatogenesis is not yet initiated since the Sertoli cells exhibit low levels of androgen
receptor. In girls, estradiol levels increase at minipuberty, and remain upregulated up for
approximately six months (Young et al., 2019). The dectectable levels of AMH at minipuberty 
in female infants suggests a mechanism for keeping primordial follicles at a resting state during 
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minipubertal HPG axis activity. AMH acts negatively on the FSH sensitivity of primordial 
follicles, and the estrogen biosynthesis in granulosa cells of the ovary (Muratoglu Sahin et al., 
2019).
Minipuberty can be a critical time-window for early diagnosis of CHH in males, since
micropenis and cyptorchidism are seen in higher frequencies in CHH and KS patients. 
Hormonal testing is not routinely prescribed, but hormonal evaluations can be performed at 
minipuberty for children born from one parent with CHH. Female infants lack the clinical 
features, and diagnosis during minipuberty is therefore rare (Young et al., 2019). Low levels 
of AMH in female infants are associated with CPP, and premature thelarche (PT) which is a 
milder form of premature activation of HPG axis that leads to premature breast development. 
The underlying cause for lower levels of AMH has, however, not been resolved (Muratoglu 
Sahin et al., 2019)
Delayed puberty
Delayed puberty is defined as 2 or 2.5 years later onset of puberty compared to the population 
mean. This is traditionally reported after the age of 14 for boys and 13 for girls. Low testis 
volume in boys and absence of breast development in girls are general criteria (Young et al., 
2019). It is still difficult to distinguish between CHH and constitutional delay of growth and 
puberty (CDGP). CDGP is related to transient GnRH deficiency that is more common in the 
general population. This diagnosis is done by exclusion of permanent forms of HH, and can 
be managed by short-term hormonal treatment or expectant observation (Palmert, Dunkel, 
2012).
The main characteristics of CHH in females is primary amenorrhea in nearly 90% of patients, 
and in 10% only one or two episodes of bleeding occurred during adolescence. Absent breast
development before hormone therapy seems to be the case only for a minority of patients. For 
males, absent or minimal virilisation, erectile dysfunction, low testicular volume due to absence 
of puberty, absence of secondary sexual characteristics, in addition to previously mentioned 
cryptorchidism and micropenis are common problems. In 75% of CHH patients, puberty never 
occurs spontaneously (Young et al., 2019).
Associated phenotypes and genetics of CHH
Anosmia has been reported in around 50% of CHH cases defined as KS. Other phenotypes 
occur at lower prevalence, such as mirror movements (synkinesia), unilateral renal genesis, 
eye movement disorders, sensorineural hearing loss, midline brain defects, cleft lip and palate,
dental agenesis, and skeletal and cardiovascular defects (Young et al., 2019).
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Some syndromic forms of CHH are associated with specific combination of phenotypes. 
Approximately 46 syndromes have reported CHH traits, some of which are known to exhibit 
also genetic overlap with CHH, including CHARGE syndrome (CHD7, SEMA3E),
Waardenburg syndrome (SOX10), and Hartsfield syndrome (FGFR1) (Marcos et al., 2014, 
Lalani et al., 2004, Cariboni et al., 2015, Pingault et al., 2013, Miraoui, Dwyer & Pitteloud, 
2011).
To date, over 30 CHH-associated genes have been discovered (Listed in: Article III, Fig. 4 A).
The development in sequencing methods and genetic techniques will hopefully lead to the 
discovery of further genes, which would be very important for achieving more efficient genetic 
diagnoses, as around 50% of cases lack molecular diagnosis. The heterogeneous genetic 
background of CHH mirrors the complex development of GnRH neurons. GnRH deficiency 
can be the result of defects in different mechanisms during the different stages of 
development, including GnRH neuron fate specification, GnRH neuron migration, axon 
guidance, abnormal neuroendocrine secretion and homeostasis, and gonadotrope defects 
(Young et al., 2019).
In the general population, the variation of age of puberty is largely genetically influenced (50-
80%). Genome-wide association studies have recently reported ca 400 independent loci 
associated with variance in the timing of puberty (age at menarche, first occurrence of 
menstruation) in ~370000 women of European ancestry (Day et al., 2017). Several of the
genes associated with age at menarche in this study where implicated in neuronal tissues 
based on transcriptome-wide association. One molecule involved in neurobiological 
repression of HPG axis before puberty is the ubiquitin ligase makorin ring finger protein 3
(MKRN3), which is expressed in the ARN before puberty onset. MKRN3 levels decrease 
during puberty (Busch et al., 2016), and loss-of-function mutations of MKRN3 are implicated
in CPP (Abreu et al., 2015, Heras et al., 2019).
4. Development and origin of GnRH neurons
GnRH neurons are born in the nasal area, emerging from the olfactory placodes during early 
embryogenesis. From the olfactory placodes, GnRH neurons take a migratory route 
intertwined with the axon fibers of the terminal nerve (TN), travelling around the olfactory bulb, 
crossing the cribriform plate to the forebrain, and making a ventral turn into to the preoptic
area of the hypothalamus (Wray, Grant & Gainer, 1989b, Schwanzel-Fukuda, Pfaff, 1989, 
Casoni et al., 2016). The development and migration of GnRH neurons is highly conserved 
across evolution (Abitua et al., 2015, Casoni et al., 2016). FGF8 is strongly implicated as a
crucial signalling molecule for GnRH neuron specification and proper development (Falardeau 
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et al., 2008, Chung, Moyle & Tsai, 2008). The most important embryonic tissues and events 
that precede GnRH neurogenesis and migration will be discussed in this section.
Craniofacial development
The embryonic face is developed by morphological movements, tissue bending, and growth 
(Helms, Cordero & Tapadia, 2005). The cranial neural crest cells migrate from the neural folds
to form the majority of the connective tissues, bones, and peripheral neurons and glial cells in 
the face. The cranial placodes form the sensory organs; the eyes, ears, and nose all contain
sensory neurons (Schlosser, 2006).
Neural crest 
The neural crest (NC) is a transient embryonic population of cells unique in their multipotency
and migratory properties, which has evolved as a trait specific to vertebrate development. NC
cells hold a potential to give rise to specialized cell types contributing to diverse tissues and 
biological functions in the body, from peripheral neurons and glia to cranial cartilage, dentin, 
skin melanocytes, and the septum of the heart (Dupin, Le Douarin, 2014). The NC thereby 
has been referred to as the “the fourth germ layer” by developmental biologists (Shyamala et 
al., 2015). The NC cells derive from the neural plate border region, located in the dorsal-most 
parts of the gastrula stage embryo, from where they migrate into their peripheral locations to 
contribute to organ and tissue development (Dupin, Le Douarin, 2014).
Based on their anterio-posterior position along the neural tube, the NC can be subdivided into
cranial, cardiac, vagal and sacral, and trunk neural crest:
The cranial neural crest cells are the source of most of the mesenchymal tissue that 
forms the facial structures, including cartilage, bone, cranial neurons, glia, as well as 
odontoblasts of the tooth primordia, and bones in middle ear and jaw. 
Cardiac neural crest gives rise to musculoconnective tissue that forms walls of large 
arteries from the heart and the aorticopulmonary septum. 
Vagal and sacral neural crest generate enteric ganglia in the gut. 
Trunk neural crest gives rise to a substantial part of the neurons and glia forming in 
the peripheral nervous system, and, in addition, secretory endocrine cells, and pigment 
cells of the skin (Bhatt, Diaz & Trainor, 2013, Shyamala et al., 2015).
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Neural crest induction at the neural plate border
The neural plate border region, which later segregates into progenitors of NC and cranial 
placodes, arises by interaction between the neural plate and epidermis. FGF, Wnt, and 
attenuated BMP are involved in the border region establishment at late blastula to gastrula 
stages (Schille, Schambony, 2017). The positioning and maintenance of the neural plate 
border region is regulated by the expression of the neural plate border specifier genes; the 
Zic, Pax, Dlx, and Msx families of transcription factors. Wnt signalling is needed to activate 
the expression of Pax3 and Msx1/2, and other neural plate border specifiers (Zic1, Zic3, Dlx5, 
Msx1/2) are responsive to BMP inhibition. After the establishment of the neural plate border 
region, these specifiers induce formation of NC by activating the expression of the neural crest 
specifier genes (Meulemans, Bronner-Fraser, 2004, Simoes-Costa, Bronner, 2015). The 
presumptive NC lies between the epidermis exhibiting high BMP signalling activity, and the 
neural ectoderm with strong BMP antagonistic activity (Figure 2) (Selleck, Bronner-Fraser, 
1996). The overlying epidermis has the capacity to ectopically induce NC in underlying neural 
plate, as shown originally by Dickinson and colleagues (Dickinson et al., 1995). BMP 
antagonists are also expressed in the underlying dorsolateral mesoderm (Steventon et al., 
2009). Together, this balanced inhibitory and activating regulation is thought to result in a 
precise level of BMP activity, generating an area permissive for NC induction (Stuhlmiller, 
Garcia-Castro, 2012) (Figure 2).
The NC fate becomes restricted in the neural plate border by expression of neural crest 
specifier genes including Snail (also known as Snai1), Slug (also known as Snai2), Pax3, 
Twist, Tfap2 (AP-2α), Foxd3, and Sox10 (Simoes-Costa, Bronner, 2015). NC specifier genes 
regulate the specification and the maintenance of multipotent NC progenitors. The NC 
specifiers also regulate downstream neural crest effector genes, which further regulate 
migration and progressive differentiation into neural crest derivatives. The progression from 
premigratory progenitor cells to migratory neural crest is enabled by the process of epithelial 
to mesenchymal transition (EMT). EMT requires altering of cell-cell adhesion properties and 
remodelling of the actin cytoskeleton to reduce cell polarity, which thereby allows changes in 
overall shape and adhesiveness of the cells (Cheung et al., 2005, Simoes-Costa, Bronner, 
2015, Werner et al., 2007). HNK-1 is a known marker for migratory human neural crest 
(Tucker, G. C. et al., 1988). In addition, protein expression of PAX3, SOX9, and SOX10 in the 
premigratory, and SOX9, SOX10, P75, and AP-2α in rostral migratory NC, have been reported
in human embryo samples (Betters et al., 2010).
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4.3.1 BMP signalling pathway
Animal models of NC induction have demonstrated the importance of BMP regulation (Prasad, 
Charney & Garcia-Castro, 2019). Modulation and magnification of the BMP signals are
reinforced by other signalling pathways, such as FGF and Wnt signals derived from the 
mesoderm (Stuhlmiller, Garcia-Castro, 2012). To define the level of BMP activation or 
inhibition required for NC induction has been a challenge. This is seen especially when 
modelling NC induction in vitro using hPSCs. Based on reported protocols for NC generation, 
at least temporary BMP inhibition is required during NC induction (Menendez et al., 2011, Mica 
et al., 2013, Hackland et al., 2017).
4.3.2 Wnt signalling pathway
Canonical Wnt signalling is an intracellular pathway that function by activating the β-catenin
signal transduction, to modulate transcription of the target cell. The Wnt signalling pathway is 
activated by secreted Wnt proteins acting as ligands to seven-transmembrane receptor 
Frizzled, and by activating its co-factors lipoprotein-receptor-related protein (LRP) 5/6 and 
Disheveled (Dvl) proteins. In the absence of Wnt ligands, β-catenin is degraded in the 
cytoplasm by a destruction complex consisting of the negative Wnt regulator Axin, glycogen 
synthase kinase-3β (GSK-3β), adenomatous polyposis coli (APC), and casein kinase 1 (CK1).
In brief, Wnt activation causes translocation of Axin and the destruction complex to the plasma 
membrane, which allows for increased free intercellular β-catenin to enter the nucleus and
induce transcription of Wnt target genes (Clevers, 2006) (Figure 1 B).
Animal models have demonstrated a role for secreted Wnts derived from the adjacent 
mesoderm in the induction of NC (Garcia-Castro, Marcelle & Bronner-Fraser, 2002, Steventon 
et al., 2009, Ji et al., 2019). Studies in Xenopus showed that the activation of Wnt pathway 
remains critical from gastrula to neurula stages, whereas the requirements for BMP signalling 
varies (Steventon et al., 2009, Prasad, Charney & Garcia-Castro, 2019). The importance of 
Wnt pathway activation in the induction of mammalian NC was later confirmed in several in 
vitro studies using human pluripotent stem cell differentiation (Menendez et al., 2011, Mica et 
al., 2013, Leung, A. W. et al., 2016). In this type differentiation experiments, small molecule 
Wnt agonists can be used for Wnt activation during differentiation, such as BIO and 1-
azakenpaullone, which act as inhibitors of GSK-3β (Sato, N. et al., 2004, Prasad, Charney & 
Garcia-Castro, 2019).
Neural crest cell multipotency
Retained developmental plasticity of NC progenitors is an important characteristic feature, and 
the gene expression profile of NC cells share common features with pluripotent blastocysts 
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cells (Thomas et al., 2008), including the expression of transcription factors. But as embryonic 
development progresses, the NC cells become integrated into developing tissues and 
differentiate terminally. Several reports suggest that neural crest stem cells are multipotent, 
and their fate depends on the environment (Bronner-Fraser, Fraser, 1989, Frank, Sanes, 
1991, Fraser, Bronner-Fraser, 1991). Lineage-tracing studies in chick revealed that individual 
premigratory cells are multipotent (Frank, Sanes, 1991). The progeny of one cell could give 
rise to neurons with distinct localization, shape, innervation, and lineage subtypes of neurons 
and glia. This has also been observed in vitro by showing that the progeny of a single NC 
generated both melanocytes and neuronal cells (Sieber-Blum, Cohen, 1980).
Yet, it has been observed that the cranial NC contributes to different cell lineages somewhat 
differently depending on the timing of migration. Early-migrating cranial NC cells contribute to 
both dorsal (melanocytes, dorsal dermis, and neurons of the ciliary ganglion) and ventral
(Schwann cells and cartilage, bone and dermis of the jaw) cell types. The late-migrating cells 
show a lesser tendency toward bone and cartilage differentiation. When early-migrating NC 
cells from the chick were grafted into late-migratory-stage of the quail, the grafted cells 
contributed to bone and cartilage formation normally. Conversely, when substituting early-
migrating cells with late, the cells no longer contributed equally to jaw skeleton and only formed 
dorsal derivatives. When late-migrating cells were grafted into a late-stage embryo lacking 
both late and early NC cells, the grafted population did contribute to jaw bone and cartilage, 
which suggests that the presence of early-migrating cells actually restricts the later-migrating 
cell differentiation (Baker et al., 1997). This illustrates the innate plasticity of the neural crest 
cells, and advocates for environmental regulation during and after migration to gradually 
restrict multipotency.
The multipotency of NC is well recapitulated in vitro, where cells are both spontaneously and
by directed differentiation able to generate a multitude of NC derivatives, as well as retain the 
capacity of self-renewal for several generations (Stemple, Anderson, 1992, Calloni, Le 
Douarin & Dupin, 2009, Kerosuo et al., 2015). However, in vivo the multipotency of NC cells 
is still a transient phenomenon, and researchers are continuing investigations into the routes 
and mechanisms of lineage restriction (Kalcheim, Kumar, 2017).
Notch signalling and neural crest development
Notch signalling acts as an important regulatory feature during tissue morphogenesis, cell fate 
decisions and differentiation, and cell-cell communication. Notch signalling is responsive to
other external signals, as well as intrinsic signalling (Sjoqvist, Andersson, 2019).
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4.5.1 Notch signalling pathway
Notch signalling is based upon cell-cell communication between ligand and receptor-
expressing cells. The mammalian Notch pathway consists of Notch receptor paralogs 
(Notch1-4) and five DLS family members of Notch ligands; Delta-like (Dll1, Dll3, and Dll4) and 
Jagged (Jagged1/Jag1 and Jagged2/Jag2). When ligands bind to Notch receptor, the Notch 
intracellular domain (NICD) is proteolytically cleaved by alpha-secretase and gamma-
secretase complexes, and translocated to the nucleus. In the nucleus NICD interacts with 
RBP-J (Recombination Signal Binding Protein, also known as CSL (CBF-1-suppressor of 
hairless-LAG-1)) and the MAML1 coactivator, and forms an active signalling complex 
(Borggrefe et al., 2016) (Figure 2 A).
The outcome of Notch signalling depends on the intercellular and intracellular context. The 
initial signal is transferred by trans-activation between the Notch ligand-presenting and 
receptor-presenting cell. The directionality of the Notch signal has traditionally been explained 
based on the models of lateral inhibition and lateral induction. Lateral inhibition produces bias 
between two equipotent cells after trans-activation, which is reinforced by downregulation of 
ligand in the signal-receiving cell, thereby inhibiting Notch activation in its contacting cells. In 
other contexts lateral induction can be  employed, for example in boundary formation, where 
a positive feedback loop enhances the expression of Notch in contacting cells, leading to a 
lateral spreading of Notch activation (Sjoqvist, Andersson, 2019). However, evidence supports 
more complex spatial and temporal regulation to determine the signalling outcome. 
Distribution of ligands and receptors is more seldom equal between cells. Thus, the signal 
progression within a tissue can be regulated in several ways, including cell polarity and 
asymmetrical expression of ligands or receptors within a cell, and cell motility (Bray, 2016).
Different ligands and receptors also produce different strength or duration of the Notch signal. 
For example, Jag1 has lower affinities for Notch1 compared to Dll4, which causes lower signal 
strength and a specific signalling outcome (Gama-Norton et al., 2015). In the case of 
receptors, Notch1 and Notch2 show variance in signal outcome even in the same pattern of 
expression. This is thought to be based on differences in stability and amount of NICD moieties 
and their availability of proteases for activating cleavage (Fan et al., 2004, Liu et al., 2013).  
In addition to trans-activation, ligand and receptor expression on the same cell can also have 
a cis-inhibitory effect, by inhibiting a cell surface receptor in the same cell. Cis-inhibition by 
ligand presenting cells reduces the levels of receptor on the cell surface available for trans-
activation. Furthermore, the Notch ligand Dll3 lacks trans-activation features, therefore having 
an inhibitory role, most likely by acting only through cis-inhibition (Bray, 2016, Ladi et al., 
2005).
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Among common targets of the NICD-RBP-J complex that act as effectors of Notch signalling
are the HES family genes. HES genes are basic helix-loop-helix (bHLH) transcription factors 
which act as repressors of several downstream targets that include tissue-specific 
transcription factors (Iso, Kedes & Hamamori, 2003). Events in the cell nucleus further regulate 
the effect on transcription of effector genes. RBP-J functions in a cell-specific manner to 
activate or inhibit different transcriptional programmes depending on the cell type and tissue. 
This can be partially explained by cooperation with tissue specific transcription factors, but 
also depends on accessible chromatin, levels of inhibitory transcription factors, and co-
repressors and co-activators (Bray, 2016).
The Notch signalling pathway plays important roles in stem cell maintenance as well as in the 
tissue differentiation. During neural crest specification, Notch signalling has been implicated 
in the regulation of the expansion vs. restriction of the NC territory at the neural plate border 
region (Mead, Yutzey, 2012) (Figure 2 B). During cortical neurogenesis, active Notch 
signalling is required for maintenance of the proliferative state of neuronal stem cells to allow 
for tissue expansion, in a process that lies downstream of FGF signalling (Rash et al., 2011).
Notch pathway can be inhibited by gamma-secretase inhibitors (GSIs) that block the cleavage 
of Notch, for example to induce differentiation in neuronal progenitor cells. The most 
commonly used gamma-secretase inhibitor is DAPT (N-[N-(3,5-Difluorophenylacetyl-L-
alanyl)]-S-phenylglycine t-Butyl ester) (Purow, 2012).
Specification of preplacodal ectoderm
The sensory organs of the face are formed by the ectodermal thickenings called cranial 
placodes, which constitute a large part of the embryonic cranial ectoderm. The cranial 
placodes are derived from the pre-placodal ectoderm (PPE), a “pan-placodal primordium” 
which consists of a crescent-shaped area around the anterior neural plate (Sclosser 2014)
(Figure 2 C). The PPE is specified by the expression of transcription factors of the Six family, 
and their co-factors, the Eyas. Eyas bind to other transcription factors, (c-terminal Eya-domain) 
and have transactivation properties (Zou et al., 2004, Laclef et al., 2003). They are transported
to the nucleus by binding to SIX, where they act as transcriptional co-activators (Ohto et al., 
1999). Six family genes are homeodomain transcription factors, out of which Six 1/2 and Six 
4/5 are known to have panplacodal expression. In vertebrates, at least one Eya gene is 
expressed in all cranial placodes, with varying distribution of paralogues depending on species 
(Schlosser, 2006). The Six genes can act as either transcriptional repressors or activators 
depending on their interaction with co-factors. In addition to Eyas, Six can bind to co-activators
and co-repressors such as Dach and Groucho, thereby modulating their activity (Brugmann et 
al., 2004). The expression of Six and Eya in cranial placodes is required for the induction of 
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neurogenic transcription factors NeuroD and Neurogenin2. In addition to the Six and Eya
genes, transcription factors such as Dlx homeobox and Gata class zinkfinger transcription 
factors are needed to acquire placodal competence. For neurogenesis, Sox genes and Irx
(Xiro in Xenopus) are important inducers (Schlosser, 2006).
Although Six and Eya expression is found in the PPE and remain expressed in the ready 
formed placodes, it is not enough to promote full development of the placodes, and co-
operation with other factors during placode development is needed (Brugmann et al., 2004, 
Christophorou et al., 2009). The area of Six and Eya expression is defined during gastrulation 
together with the other domains within the neural plate border region; the neural crest, 
epidermis, and the neural plate (Figure 2 C). Signals from these areas and the underlying
mesoderm, such as FGFs, BMP inhibitors, and Wnt inhibitors induce and restrict the PPE 
territory (Litsiou, Hanson & Streit, 2005).
Further on in the development, the preplacodal ectoderm will become subdivided into distinct 
cranial placodes. Rostrally the adenohypophyseal placode, the only single placode in contrast 
to the other paired cranial placodes, produces neuroendocrine cells of the anterior pituitary, 
including ACTH, PRL, TSH, FSH, GH producing cells (Asa, Ezzat, 2004, Sanchez-Arrones et 
al., 2017). Other anterior placodes include the paired olfactory and lens placodes. The lens 
placode gives rise to the lens of the eye. The olfactory placode (OP) gives rise to sensory 
neurons and epithelia that form the sense of smell, as well as the pheromone-sensing 
vomeronasal epithelia of the vomeronasal organ (VNO). The otic placode gives rise to sensory 
hair cells, supporting cells, and endolymph producing cells of the inner ear (Whitfield, 2015).
The epibranchial, profundal, trigeminal, hypobranchial and the paratympanic placodes, are 
neurogenic placodes which generate various sensory and somatosensory neurons of the face 
(Schlosser, 2014).
Development of the olfactory placodes
Placodal ectoderm becomes regionally specified by the expression of various homeobox 
genes that roughly define the anterioposterior and dorsoventral subregions of the placodal 
ectoderm. In the anterior placodal domain, where the OPs reside, there is expression of Otx2, 
Emx2, Six3/6, ANF, Pitx, and Pax6 (Simeone et al., 1992, Oliver et al., 1995, Grindley, 
Davidson & Hill, 1995, Lagutin et al., 2003, Dutta et al., 2005, Schlosser, 2006).
It has been suggested that a lens-identity bias is initially established for the anterior placodes 
by the expression of Dlx5 and Pax6, and OP identity is acquired by cells sustaining Dlx5,
whereas it is downregulated in the lens placode (Bailey, A. P. et al., 2006, Bhattacharyya et 
al., 2004, Long et al., 2003). Fgf8 in the anterior neural ridge promotes specification of the 
olfactory placode, while supressing lens placode (Bailey, A. P. et al., 2006).
28
Studies from zebrafish have demonstrated that OP structures are established by 
morphological movements at the end of gastrulation (Whitlock, Westerfield, 2000, Harden et 
al., 2012). From the anterior neural plate border region, the presumptive OP cell population 
migrates anteriorly away from the neural plate, and becomes gradually separated from the 
forebrain by migrating neural crest cells (Torres-Paz, Whitlock, 2014). Once established, the
ectoderm thickens and invaginates to form the olfactory pit and olfactory epithelia, which will 
comprise respiratory and sensory (olfactory receptor neurons) epithelium. Here, 
neuroepithelial induction versus respiratory fate is regulated by opposing action of BMP and 
FGF signalling (Maier et al., 2010).
Figure 2. Notch signalling, neural crest, and preplacodal ectoderm induction.
A) Notch signalling is based on cell-cell signalling between a signal sending and signal-receiving cell. 
Ligand binding to the Notch receptor induces the cleavage of the Notch intracellular domain (NICD),
which forms a complex with CLS and MAML1 in the nucleus. B) During the induction of neural crest in 
the neural plate border area, BMP and Notch pathways are involved in patterning and restriction of the 
presumptive NC during development, by activation of NC specifier genes (Rogers et al., 2012). C) The 
preplacodal ectoderm form in a crescent-shaped area in the NPB of the anterior embryonic ectoderm, 
and becomes separated from the presumptive NC by expression of PPE-specific transcription factors. 
NBP = neural plate border, NT = neural tube, NC = neural crest, PPE = Preplacodal ectoderm, D =





Neurogenesis in the olfactory placode
FGF8 is an important morphogen during OE neurogenesis. Mutations in FGF8 signalling in 
mice cause defects in olfactory neurogenesis and GnRH neuron specification (Chung, Moyle 
& Tsai, 2008, Falardeau et al., 2008, Chung et al., 2010, Sabado et al., 2012). During the 
invagination and formation of the murine nasal pit, Fgf8 is expressed by ectodermal cells 
around the outside border of the forming pit (Figure 3 A), (Kawauchi et al., 2005). The entire
epithelium inside the pit expresses stem cell marker Sox2. Alignment of neuronal cell types 
lies in an outside-in organization, with the youngest cells at the outer rims, next to the Fgf8-
expressing cells, expressing Ascl1 (formerly known as Mash1). Ngn1-expressing intermediate 
neuronal progenitors lie next to the Ascl1 region, and in the center of the pit Ncam-expressing 
postmitotic neurons are becoming olfactory receptor neurons (ORNs) (Kawauchi et al., 2005).
Foxg1 is also expressed by the neuronal progenitors of the OE, and Fgf8 exhibits a 
paracrine/autocrine role in their survival by regulating the normal expansion of the epithelium 
required for differentiation of all neuronal cell types. Conditional knockout of Fgf8 in the Foxg1-
expressing cells leads to apoptosis of the early Sox2-positive cells at the outside rim of the 
olfactory pit, and eventually halts neurogenesis in the whole OE (Kawauchi et al., 2005). Fgf8 
regulates the dosage of Sox2, so that a ventro-medial to dorso-medial gradient of Sox2 is 
generated proximal to the source of secreted Fgf8. At the same time, an opposite ventro-
lateral gradient of Meis1, expressed by slow dividing multipotent stem cells, is formed in cells 
exhibiting low Sox2 expression. Meis1 represses Ascl1, while Sox2 promotes Ascl1 
expression in rapidly dividing neuronal progenitors. Fgf8 is thought to promote the generation
of transit amplifying Ascl1-expressing progenitors, responsible for expansion of the 
intermediate neuronal progenitors that give rise to differentiated neurons. Thus, Fgf8 creates
a transcriptional network that modulates the proliferative status of the cells in the OE (Tucker, 
E. S. et al., 2010).
GnRH neurons express Fgfr1 and Fgfr3, and both act as receptors for Fgf8, but Fgfr1 has 
been primarily implicated in olfactory neurogenesis and GnRH neuron differentiation (Mott et 
al., 2010). Fgf8 and Fgfr1 hypomorphic mice show craniofacial anomalies during 
embryogenesis, including a reduction in the number of GnRH neurons (Meyers, Lewandoski 
& Martin, 1998, Chung, Moyle & Tsai, 2008). Fgf8 and Fgfr1 homozygous hypomorphs 
retained small OP-like thickenings and partial invagination of the pit. At E11.5, when GnRH 
neurons have normally appeared, GnRH was not detected in homozygous Fgf8 hypomorphs, 
and was completely absent at birth. Fgfr1 hypomorphs also presented a significantly lower 
number of GnRH-positive neurons at E11.5. The Fgfr3 KO mice did not present any significant 
change in GnRH neuron numbers, which suggest that FGF8 is acting on GnRH neurogenesis 
mainly through FGFR1, but, however, small compensation through FGFR3 cannot be ruled 
out (Chung, Moyle & Tsai, 2008, Gill, Moenter & Tsai, 2004).
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Forni and colleagues further described the developing OE and nasal pit, and found that the 
Fgf8-expressing cells reside in an area containing AP2α- and MSX1/2-positive cells, which 
mark respiratory epithelia (RE) in the rostral part of the nasal pit in E11.5 mice embryos (Forni 
et al., 2013). This Fgf8-positive area in the RE coincided with low levels of BMP4, but not with 
the neuronal progenitor marker HuC/D, which is found only distally form the Fgf8 source. High 
levels of BMP4 expression, and active SMAD 1,5,8 surrounded the rostral nasal pit and 
epithelial rims, and high expression of Noggin was detected in the mesenchyme. Neurons in 
the OE always appeared proximal to the high Noggin area. GnRH neurons appeared in the 
area juxtaposed to the Noggin source in the ventromedial OP, and GnRH neurons were found 
in increasing number from the rostral to caudal midface (Forni et al., 2013). Noggin expression 
can be triggered by active BMP, and is crucial for neurogenesis in the OE (Maier et al., 2010).
This suggests that the ventromedial mesenchymal source of Noggin, proximal to the Fgf8 
source in the RE, attributes a GnRH neurogenic niche (Figure 3 B). Decrease in Fgf8 
expression led to considerable changes in the areas of Bmp4 and Noggin expression in the 
OP, which severely disrupted neurogenesis and morphogenesis in and around the OP area. 
Thereby, the effect of Fgf8 (and Fgfr1) mutations on loss of GnRH neurons may be partially 
secondary to the changes caused by dysregulation of Bmp signalling (Forni et al., 2013). That 
does, however, not provide comprehensive evidence to completely rule out a role for Fgf8 in 
neuronal linage specification, as was previously suggested (Kawauchi et al., 2005, Tucker, E. 
S. et al., 2010). Fgf8 has been implicated in survival and sustained proliferation, (inhibiting 
neuronal differentiation) as well as positional patterning of neuronal stem/progenitor cells
(Lahti et al., 2011, Crespo-Enriquez et al., 2012, Storm, Rubenstein & Martin, 2003). So far, 
the exact mechanism of FGF8 on GnRH neuron progenitor cells has not been resolved.
Origin of GnRH neurons?
After the discovery of GnRH neurons arising within the olfactory placodes and migrating to the 
hypothalamus in association with the terminal nerve, the dogma of OP neuronal progenitor 
origin was challenged with the hypothesis that the NC could contribute to the OP, giving rise 
to a subset of GnRH neurons (Whitlock, Wolf & Boyce, 2003, Forni et al., 2011). A study
conducted in zebrafish proposed that the neurons expressing GnRH near the terminal nerve 
in the frontonasal area and the hypothalamic GnRH neurons would be derived from separate
progenitor populations (Whitlock, Wolf & Boyce, 2003). The NC would give rise to the TN 





Figure 3. Neurogenesis in the olfactory epithelium and emergence of GnRH neurons in mice. A) 
In the developing nasal pit, Fgf8 is expressed by cells at the rostral tip of the invaginating epithelium. 
Figure drawn based on (Kawauchi et al., 2005, Tucker, E. S. et al., 2010, Forni et al., 2013). B) 
Emergence of GnRH neurons in the frontonasal mesenchyme, proximal to the areas expressing Fgf8 
and Noggin, at the border of the presumptive VNO. Postmitotic GnRH neurons migrate toward the 
forebrain, in groups of cells called the migratory mass. C) As they enter the brain, GnRH neurons 
diverge as a dorsal route to the forebrain, and a ventral route to the hypothalamus (left panel). In the 
adult (right), hypothalamic GnRH neurons send their dendrons, which split into axons as they enter into 
the median eminence. KDNY neurons modulate GnRH secretion to the gonadotropes in the anterior 
pituitary, CHH-associated genes are listed under their suggested roles in GnRH neuron biology 
(Stamou, Cox & Crowley, 2015, Young et al., 2019). 
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The hypothesis about adenohypophyseal origin is, however, conflicted by the fact that GnRH 
neurons are normal in mice lacking the anterior pituitary (Metz, Wray, 2010).
The Cre-loxP system allows for conditional genetic recombination, that has been a ground-
breaking technique for mammalian cell-lineage tracing. Expression of a reporter allele 
combined with a Cre recombinase-expressing line leads to tissue-specific reporter expression, 
which can be used to trace stem cells and their progeny. The Wnt1-Cre transgenic mouse line 
(Danielian et al., 1998) expresses Cre in premigratory NC cells in the dorsal neural tube, and 
in combination with the ROSA26 (R26R) Cre-reporter line, recombination can be detected by 
reporter expression in approximately 96% of migratory NC cells (Debbache, Parfejevs & 
Sommer, 2018). In the study by Forni and colleagues, the transgenic mouse line Wnt1-
Cre;R6RYFP+ was used to label NC cells, and some of the reporter labelling was found within 
the OP, overlapping with GnRH+ immunolabeling (Forni et al., 2011). They thereby proposed 
that both the OP and NC would be able to contribute to the GnRH neuron population. 
Shortly thereafter, conflicting evidence arose from the chick embryo (Sabado et al., 2012). By 
grafting of the neural folds (the source tissue of NC), from transgenic GFP-chick embryos to 
WT hosts, Sabado and colleagues found that GFP+ cells enter the frontonasal mass and 
surround the olfactory nerve but do not integrate to the OE, and no GnRH1+ cells were found 
positive for GFP. By labelling using focal injections of lipophilic dyes in either OP or
adenohypophyseal placode, they discovered that GnRH+ cells are born within the OP, and 
not from the anterior pituitary progenitors. Nasal explant cultures from different developmental 
stages showed that OSNs begin to be specified before GnRH neurons, which are specified in 
a short time window at HH16-17, and have already specified terminally by HH20. The authors, 
furthermore, express concerns about the reliability of mouse Wnt1-Cre;R6RYFP+  which was 
used by Forni and colleagues, as it had shown ectopic labelling of cells in telencephalon and 
retina. Moreover, Barraud and colleagues had previously shown that NC cells contribute to 
the olfactory ensheating cells (OECs), glial cells that surround the olfactory nerve, but no 
contribution to olfactory neuronal cell types have been reported since (Barraud et al., 2010).
Another study conducted in zebrafish also showed that NC cells do not mix with OP cells 
during OE development, but that NC cells remain in close association with the OP, giving rise 
to OECs that surround the olfactory nerve (Harden et al., 2012). This was later supported by 
studies using a Sox10-mutant model, which disrupted development of many cranial NC 
lineages including OECs, but did not affect GnRH neurons (Aguillon et al., 2018). This study 
also showed backtracking of anterior PPE and in vivo, which revealed that precursors of 
GnRH+ cells were backtracked to the anterior PPE which lies close to the progenitor region 
of the adenohypophyseal placode (Dutta et al., 2005). Neuronal progenitors were not 
backtracked to the NC, which further argues against NC contribution to the OP, and supports 
the hypothesis that “cell type heterogeneity in the zebrafish olfactory epithelium is generated 
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from progenitors within the PPE” (Aguillon et al., 2018). In human foetuses, SOX10-
immunolabeling has not been reported to co-localize with GnRH neurons, albeit they were 
detected in close association with SOX10-positive ensheating cells (Casoni et al., 2016).
So far, all these data point that GnRH neurons are being specified in the OP from neuronal 
stem cells of preplacodal origin, and they acquire the required linage competence under the 
paracrine influence by FGF8 and Noggin. Six1-positive cells in the non-neuronal ectoderm, 
the PPE, become further restricted by local signals to give rise to the olfactory placode. OPs 
are either assembled separately from rostrally migrating cells or as a two gradually segregated 
groups of the rostral tip of the telencephalon, which converge rostrally from lateral populations 
of the neural tube, and eventually become separated from the forebrain by groups of NC cells
during facial morphogenesis. Further support on NC origin has not been acquired in the last 
~10 years. With increasing development in the field by single-cell sequencing and CRISPR-
based genome editing, new data on this matter are expected to take us forward during the 
following 10 years, to hopefully get an answer to the question of GnRH neuron ontology.
Emergence and migratory path of GnRH neurons during embryogenesis
The first report on GnRH neurons in the mouse nasal region dated the emergence of GnRH 
neurons to embryonic day 11 (E11). Cytoplasm GnRH-immunoreactivity (Then called LHRH) 
was detected from E11 forward in the medial OP in cells with axons that appeared to be 
coming out from the epithelium of the VNO. As a sign of migration, GnRH-positive cells were 
detected entering the brain at E14, and at E16 in the septal preoptic area (Schwanzel-Fukuda, 
Pfaff, 1989) (Figure 3C). Further characterization revealed increased labelling of GnRH mRNA 
and peptide at E11.5- E12.5 in the nasal mesenchyme (Wray, Grant & Gainer, 1989b). At 
E12.5, a total number of approximately 800 GnRH-expressing neurons were counted, and 
90% of these were found in the nasal area. The GnRH neurons that were detectable by 
immunohistochemistry also expressed markers for postmitotic neurons. To approximate the 
birthdate of the GnRH neurons, immunohistochemistry was combined with 3H-thymidine 
autoradiography, which suggested that most of the GnRH neuron precursors underwent their
final mitotic division between E10.5-E12.5, with the highest 3H-thymidin labelling in GnRH 
neuron at E11.5.
In a human foetus, GnRH immunoreactivity was discovered at the ~42nd day of gestation, but 
not at the earlier stages examined (days 28-32 of gestation) (Schwanzel-Fukuda et al., 1996).
At day 42, the TN was observed as axon fibers spanning from the medial nasal mesenchyme, 
and entering the forebrain medially to the olfactory bulbs, in the direction of the ventral septal 
regions of the brain. GnRH-expressing cells were observed as a continuous stream from the 
nose to the preoptic area, always in contact with N-CAM expressing nerve fibers. A highly 
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sialated form of N-CAM was also detected by using PSA-NCAM antibodies in certain parts of 
the migratory pathway in close association with GnRH neurons. The polysialic forms of N-
CAM have been implicated in lower cell adhesiveness in contrast to the stable, highly adhesive 
N-CAM (Rutishauser, 1996, Johnson et al., 2005) which is abundant along the terminal and 
vomeronasal nerves. This suggested that contact with the less adhesive PSA-NCAM may 
facilitate acceleration of movement away from the olfactory epithelium, and that the stable 
connection to less sialated NCAM fibers may serve as guides for along the migratory stream 
(Schwanzel-Fukuda et al., 1996, Yoshida et al., 1999). More recently, a subset of human 
foetuses were investigated using immunohistochemistry and DISCO tissue-clearing 
techniques, for further characterization GnRH early emergence and migratory pathway 
(Casoni et al., 2016). In the human foetus, the OPs have invaginated and formed olfactory pits 
by Carnegie stage (CS) 16, around 39 days of gestation. In the medial part of the OP, a small 
loop of the invaginating epithelia forms the presumptive vomeronasal organ (pVNO). At CS 
16, a small number of GnRH neurons have emerged in the medial nasal mesenchyme 
proximal to the pVNO basal lamina, seen as GnRH-immunopositive cells that co-express the 
immature neuron marker Doublecortin (DCX) (Gleeson et al., 1999). Thus, the point of GnRH 
neuron specification likely occurs at 5-6 weeks of gestation. As shown in the mouse, the
emerging GnRH neurons co-express markers for postmitotic neurons, which suggests that 
they have terminally differentiated at the stage when GnRH expression is detectable (Casoni 
et al., 2016). In total, Casoni and colleagues reported approximately 10 000 GnRH-expressing 
neurons in human foetuses from CS16-21. 
At the onset of their migration, GnRH neurons converge into a group of migratory cells in the 
nasal mesenchyme, called the migratory mass. The migratory mass contains also other cells 
expressing DCX and TUJ1 in addition to GnRH-expressing neurons. The migratory mass 
moves along VNO and TN axon bundles in the nasal septum during CS 18-20. At CS 18 the 
first GnRH neurons have already entered the brain. Detected in a CS 21 embryo, Casoni and 
colleagues describe GnRH neurons migrating in a chain-like organization along Peripherin-
expressing sensory and motoneuron axon fibers that project into the forebrain. Surprisingly, 
the GnRH neurons take two different streams; the first one takes a loop that turns ventrally 
towards the hypothalamus, similarly to previous reports (Schwanzel-Fukuda et al., 1996), and 
another migratory stream appears to be directed toward the pallial and subpallial 
telencephalon (Figure 3 C). GnRH immunopositive cells were also found around the OBs, 
cerebral cortex, hippocampus, piriform cortex, amygdala and habenula (Casoni et al., 
2016). The putative functions of the extrahypothalamic GnRH-expressing neurons are not 
known. 
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How is GnRH neuron migration regulated?
Many guidance molecules and their receptors have been implicated in the regulation of GnRH 
neurons’ migration from the nose to the brain, and are associated with GnRH deficiency in 
developmental disorders (Cariboni, Maggi & Parnavelas, 2007, Wierman, Kiseljak-Vassiliades 
& Tobet, 2011). In addition to the previously mentioned N-CAM, other reports include:
Netrin-1 and its receptor DCC, expressed in GnRH neurons (Schwarting et al., 2001, 
Schwarting et al., 2004),
Reelin, the ECM protein, which repulses of GnRH migration (Dairaghi et al., 2018),
Nelf, the nasal embryonic LHRH factor (Kramer, Wray, 2000, Xu et al., 2010),
Ephrins, the contact-dependent signalling molecules and their receptor tyrosine kinases 
(Gamble et al., 2005),
Semaphorins (SEMAs), their Neuropilin receptors (NRPs), and the Plexin co-
receptors (Cariboni et al., 2007, Messina et al., 2011, Hanchate et al., 2012, Messina, 
Giacobini, 2013, Oleari et al., 2019),
SDF1, the chemokine attractant, and its receptor CXCR4 (Schwarting et al., 2006),
HGF and its receptor Met (expressed in early migrating GnRH neurons (Giacobini et al., 
2007)).
In mice, the depletion of ARX1, a homeodomain transcription factor expressed by neuronal 
progenitors of the OB, causes severe tangling of the olfactory and vomeronasal nerves. A
recent study using ARX1 (null) mutant mice showed that the development of the olfactory 
bulbs, and their olfactory and vomeronasal axonal connections are not crucial factors for 
GnRH migration into the brain (Taroc et al., 2017). Instead, the terminal nerve is the most 
prominent scaffold for GnRH neuron migration. Taroc and colleagues detected different 
guidance receptors for the TN compared to vomeronasal and olfactory axon fibers; the 
vomeronasal and olfactory nerves, but not the GnRH neurons nor the TN, exhibit strong 
expression of Neuropilin 1 & 2, receptors for the Sema3 family of secreted guidance molecules 
(Schwarting et al., 2000, Cariboni et al., 2007). Sema3A expression was seen in the forebrain 
behind the olfactory bulb, and was thereby suggested to prevent the vomeronasal and 
olfactory axons from entering the brain, and staying in the olfactory bulbs, whereas the GnRH
neurons were found to enter the Sema3A-expressing area, along with the TN.
Other guidance molecules, Slit1, Slit2, and the Robo receptors, also showed similar 
differences. Strong cortical and forebrain expression of Slit1 repels Robo1- and Robo2-
expressing olfactory and vomeronasal fibers from entering the brain (Nguyen-Ba-Charvet et 
al., 2008). GnRH neurons and TN do not express Robo1 or 2, but instead they do express 
Robo3, which silences Slit-mediated repulsion (Taroc et al., 2017).
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The neural crest-derived OECs are closely associated with GnRH neurons during their 
migration along the TN (Geller et al., 2013). OECs have been implicated in migratory 
guidance, and survival of olfactory axons and GnRH neurons during their migration to the 
brain (Barraud et al., 2013). The Notch pathway is involved in regulating the differentiation and 
maturation of OECs. Activated Notch/RBP-J suppresses neuronal differentiation, and 




To recapitulate and study the embryonic development of GnRH neurons in vitro, by 
using human pluripotent stem cells:
I. To derive multipotent neural crest progenitor cells and cranial neural crest by 
differentiation of human pluripotent stem cells, in order to investigate the disease 
mechanisms of Kallmann Syndrome
II. To generate a protocol for differentiation of GnRH neurons from human 
pluripotent stem cells in vitro.
III. To isolate and characterize the developmental transcriptome of hPSC-derived




No new hIPS cell lines were generated. Human pluripotent stem cell lines used in this work 
were existing cell lines acquired from WiCell (H9 hESCs), and the Biomedicum Stem Cell 
Center, University of Helsinki. No patient cell lines were used in this work.
Human foetal work was performed at INSERM, Lille, France, in the laboratory of Paolo 
Giacobini in accordance with French bylaw (Good practice concerning the conservation, 
transformation and transportation of human tissue to be used therapeutically, December 29, 
1998). The permission to use non-pathological human foetal tissues was granted by French 
Agency for Biomedical Research (Saint-Denis la Plaine, France, protocol no. PFS16-002).
5. Article I
Culture and maintenance of human pluripotent stem cells and DNA transfections 
We cultured H9 hESCs (WiCell) and Hel11.4 iPSCs (Mikkola et al., 2013) on GeltrexTM- (Life
technologies) coated plates with StemPro (Invitrogen). We passaged cells using collagenase 
IV (Invitrogen), and scraped the bottom of the wells using a cell scraper to detach cells from 
the culture dish, so that cells remained in small colonies in the suspension. We performed 
transfection with Lipofectamine 2000 (Invitrogen) as described in (Noisa et al., 2010). We split 
cells when confluent in 1:2 ratio using 0.02% EDTA (Sigma) into a Geltrex-coated culture dish 
24 hours before transfection. We initiated selection (G418) 48 h after transfection, at 200 
mg/ml for 3 weeks. We manually picked surviving colonies to separate wells in 24-well plate 
for expansion. 
shRNA-mediated knockdown of JAG1 and overexpression of human NICD1
We used previously described siRNA for JAG1 (Choi et al., 2008), with the target sequence 
for JAG1: 59-AGGATAACTGTGCGAACATC-39, and scrambled siRNA: and 59-
GGGCGTCGATCCTAACCGG-39. We annealed and cloned the sequences to pSuperior-Neo 
plasmid, driven by the H1 promoter (OligoEngine). We obtained the human NICD1 sequence 
from Addgene [plasmid 17623 (Yu, X. et al., 2008)] and subcloned it into a vector containing 
the CAG promoter and a G418 resistance cassette.
Neural crest, neural lineage and mesenchymal derivative differentiation 
For neural crest cell differentiation, we optimized a previously reported protocol in our lab 
(Menendez et al., 2013). We passaged confluent hESCs with EDTA 0.02% in PBS on Geltrex-
coated dishes with StemPro. After 24 hours (or at approx. 75% confluency) we added N2B27 
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medium supplemented with 2 μM Dorsomorphin (Sigma) and 5 μM 1-azakenpaullone (GSK3-
β inhibitor, Sigma). We changed medium every other day, and passaged cells with TrypLE 
(Invitrogen). For neural differentiation after pNCCs establishment, we added 20 μM DAPT 
(Sigma) to the same culture medium. We used StemPro Osteogenesis Kit, StemPro 
Chondrogenesis Differentiation Kit and StemPro Adipogenesis Differentiation Kit (Invitrogen) 
for osteocyte, adipocyte, and chondrocyte lineage differentiation of pNCCs. For neural 
differentiation of hPSCs, we used 2μM Dorsomorphin without adding other factors. 
Immunocytochemistry 
We fixed cells using 4% paraformaldehyde (10’), and blocked unspecific proteins with 10% 
foetal bovine serum and 0.1% Triton X-100 in PBS (1 h), then incubated the primary antibody 
over night at 4˚C, washed with PBS, and then we applied secondary antibodies (45’, RT). We 
mounted coverslips onto microscope slides using Vectashield mounting medium with DAPI 
(Vectorlabs). 
Flow cytometry 
We detached the cells with trypsin-EDTA and washed with PBS. We stained cells for 
antibodies against cell-surface antigens on ice and we analysed the samples with FACScan 
(BD Biosciences) using CELLQUEST software (BD Biosciences), using 10,000-20,000 cells 
per sample. For antibodies against nuclear proteins, we fixed the cells with 4% 
paraformaldehyde (15’), permeabilized with 100% ethanol for (2‘) and treated with 10% goat 
serum (15’) after washing with PBS. We incubated samples with primary antibodies (30’), and 
secondary antibodies (30’) before the analysis.
Migration assay 
We used wound-healing assay to measure migration. We cultured cells until confluent and 
made a scratch using a 10 μl pipette tip. We then observed cell migration after 24 and 48 
hours under a light microscope.
Microarray transcription profiles 
We extracted total RNAs from the samples using the All Prep DNA/ RNA/Protein Mini kit 
(Qiagen), and assessed the quality of the RNA using a 2100 Bioanalyzer and RNA 6000 Nano 
kit (Agilent). We performed transcriptome analysis with Illumina Human HT-12 Expression 
BeadChip according to the manual provided by Illumina. We pre-processed the raw data using 
the lumi package in R (Du, Kibbe & Lin, 2008), including background correction, variance 
stabilization, and quantile normalization. We removed duplicate probe sets with genefilter 
package in R by retaining the probe set with the highest interquartile range. Present and 
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absent calls for the probe sets were obtained by using the detection P-values. We performed 
differential expression analysis using an unpaired moderated t-test as implemented in limma 
in R (Smyth, 2004).  Threshold for differentially expressed genes according to Benjamini-
Hochberg adjusted P-value as 0.05 and the log fold change < -1, or > 1. The GEO accession 
number for data deposition is GSE53203. 
Reverse transcription and real-time PCR 
We used RNA Spin II kit (Macherey-Nagel) for RNA extraction according to the manufacturer’s 
instructions. We synthesized first-strand cDNA using SuperScript III reverse transcriptase 
(Invitrogen) with oligo dT primer (Invitrogen). We included 1% of the resulting cDNA in a 20 μl 
mixture containing 10 μl of SYBR Green Taq solution (Sigma) and 5 μl of 2 μM primer mix. 
We performed PCR reactions using Corbette thermal cycler (Qiagen) for 40 cycles of 95˚C for 
15 s, 60˚C for 30 s and 72˚C for 30 s. We calculated relative expression by calibrating their 
CT values to that of the housekeeping gene (cyclophillin G, also known as PPIG) and 
normalized to the expression level in hESCs (day 0) by ΔCT method.
Chromatin immunoprecipitation 
We performed Chromatin immunoprecipitation and real-time PCR with Agarose ChIP Kit as 
described in the manufacturer’s protocol (Thermo Scientific, Pierce). We had 26106 cells 
crosslinked by the addition of formaldehyde into the medium to a final concentration of 1% for 
10‘ at 37˚C, and quenching by glycine to the final concentration of 0.125 M for 5’ (RT). We 
digested cell extracts with micrococcal nuclease (MNase) for 15‘ at 37˚C. We mixed 
fragmented chromatic with 5mg of anti-NICD1 antibody (Cell Signaling Technology, #4147) 
and 5 mg of normal rabbit IgG (provided with the kit), and left on rotating wheel o/n at 4˚C. We 
added 20 ml of Protein-A/G-plus–agarose beads and incubated for 3 h at 4˚C. After the elution 
of the immune complexes, we extracted the DNA and performed real-time PCR with specific 
primers. We used fold enrichment method to determine the level of enrichment of NICD1 at a 
particular region of DNA, taking into account the total chromatin (input) and any non-specific 
binding (normal rabbit IgG). 
6. Article II
Cell lines
For differentiation experiments, we used the hESC line H9 ((Thomson et al., 1998); Wicell) 
and two hiPSC lines HEL11.4 (Mikkola et al., 2013) and HEL24.3 (Trokovic et al., 2015), 
provided by the Biomedicum Stem Cell Centre, University of Helsinki Finland. Cells were 
cultured on Geltrex-coated plates with StemPro (Thermo Scientific) or Essential 8 (Thermo 
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scientific) mediums. We always switched to StemPro before starting a differentiation 
experiment, in order to acquire a confluent plate of cells, which is not possible in E8 medium.
Differentiation procedure
For GnRH neuron differentiation, we used N2B27 medium. On days 0-10 the medium 
contained 2 μM dorsomorphin, and 10 μM SB431542 (Sigma). We passaged the cells in 1:2 
ratio on day 10, with collagenase IV (Invitrogen) and supplemented medium with 10 μM Rock 
inhibitor Y37632 (Sellekchem) over night. On days 11-20 medium containing 100 ng/ml FGF8 
(Peprotech) we refreshed daily. Another split was performed at day 20, in ratio 1:6-1:8 using 
0.5 mM EDTA in PBS (Invitrogen). On days 21-27 (and onwards) we supplemented the 
medium with FGF8 and 20 μM Notch inhibitor DAPT* (Sigma). Control cells did not receive 
FGF8 supplementation. After day 21 we refreshed medium every other day.
*After this article we have started using DAPT provided by Selleckchem, as the product was no longer 
available from Sigma.
Analysis of GnRH Expression and Secretion
We extracted RNA from cell material using Nucleospin RNA kit (M&N), and reverse 
transcription using Superscript III (Thermo Fischer). We performed qPCR using HOTFIREpol 
SolisGreen qPCR mix (SolisBioDyne), and ran samples in LightCycler 480 (Roche). We 
normalized ct values to cyclophilin G, and compared with undifferentiated hPSCs (Relative 
expression, ΔCT method). For immunocytochemistry, we fixed cells by 4% paraformaldehyde,
and immunostainings were performed using standard protocols (described in detail in 
Supplementary methods, article II and III). FOXG1 and GnRH immunopositive cells were 
quantified by manually counting the cells in images taken with a 40x objective (n=3 
independent experiments). We quantified secreted GnRH from cell culture medium by a 
competitive fluorescent enzyme immunoassay (Phoenix Pharmaceuticals).
Human samples immunohistochemistry
Validation immunohistochemistry was performed at INSERM in Lille, France. One human 
foetus (8 gestational weeks) was obtained from a voluntarily terminated pregnancy with the 
parent's written informed consent. The permission to utilize human foetal tissues was obtained 
from the French agency for biomedical research (Agene de la Biomédecine, Saint-Denis la 
Plaine, France, protocol no. PFS16-002). Tissues were made available in accordance with 
French bylaws. Tissues were fixed with 4% paraformaldehyde and immunostaining was 
performed on 20 μm cryosections. Immunostaining was performed according to standard 
procedures (P.G. INSERM, France).
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Statistical Analyses
In the text and figures, “n” stands for number of independent experiments. We performed 
statistical comparisons using paired ratio t-test in Prism 5.0 (GraphPad). p < 0.05 was 
accepted to indicate statistical significance.
7. Article III
Generation of GNRH1-TdTomato reporter cell line
We generated the reporter cell line using CRISPR-Cas9. Our strategy was to target the stop 
codon at the GNRH1 gene for insertion of donor template 
GNRH1_T2A_NLS_TdT_PGK_puro. The donor template contained homologous arms of 
577bp (5p) and 599 bp (3p) for homologous recombination into genomic DNA in hPSC lines 
H9 and HEL11.4. We cloned homologous arms by PCR from the genomic DNA of the human 
embryonic stem cell line H9 with primers containing BamH1 and Nhe1 (5p homologous arm) 
and Ascl1 and Xba1 (3p homologous arm) restriction sites for cloning, and PCR purified 
(NucleoSpin Gel and PCR Clean-up, Macherey-Nagel) and digested the fragments. We then 
purified them from the agarose gel and ligated to the donor template vector T2A-2xNLS-
TdTomato-PGK-Puro. We designed Guide RNA sequences using [crispr.mit.edu/Guides] and 
amplified and purified guide cassettes as described previously (Balboa et al., 2017).  
Electroporations and expansion of the reporter clones
After culturing hPCS lines HEL11.4 and H9 in StemPro (Thermo Fisher Scientific), we 
dissociated the cells with Accutase (Life Technologies) and resuspended them in cold 5% 
FBS/PBS. We performed three electroporations using Neon Transfection system (Life 
Technologies) according to manufacturer’s instructions, with a total of 6x10E6 cells with 18 μg 
CAG-Cas9 (Addgene plasmid ID 89995), 6 μg pUC-GNRH1-T2A-NLS-TdT-PGKPuro, and 1.5 
ug guide RNA using a pre-optimized program (1100V, 20 ms, 2 pulses). We then plated cells 
onto Matrigel matrix-coated (Corning) dishes with 10 μM ROCK inhibitor (Y-27632 2HCl, 
Selleckchem) in StemPro, and changed to StemPro with 5 μM ROCK inhibitor on the following 
day. We removed ROCK inhibitor after 48h, and started selection using 0.15 μg/ml Puromycin 
(Sigma) after 72h. We picked surviving colonies onto Matrigel coated 96-well plates in 
StemPro + 5 μM Rock inhibitor around 7-10 days after electroporation.
Screening for reporter integration
For DNA isolation, we treated the cell colonies with 0.5 mM EDTA (Invitrogen) for 4 min, and
replaced EDTA with 100 μl StemPro + 10 μM ROCK inhibitor, and detached cells by scraping 
with a 10 μl pipette tip. We took half of the suspension to a V-bottom plate for lysis, and left 
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the other half for continued culture. We centrifuged the V-bottom plate to remove supernatant 
and lysed cells in 60 μl PCR Direct lysis buffer (Viagen Biotech) and 5 μl Proteinase K, and 
incubated the cells at 55°C/2h, and 85°C/1h, and then froze at -20°C until use. We performed 
touchdown PCR for detection of integration of the 5’ and 3’ homology arms using primers and 
conditions listed in Supplemental Text 1 of article III, Lund et al 2020.
Differentiation
After screening of the insertion sites into the correct genomic location, we thawed and 
expanded three clones per cell line for differentiation into GnRH neurons, as previously 
described in article II, Lund et al., 2016, and selected the most efficient TdTomato-expressing 
clones for further experiments. We isolated TdTomato-positive cells by FACS on days 25 and 
27 of the differentiation protocol for RNA sequencing.
Fluorescence-activated cell sorting
We prepared single cell suspensions of the differentiated neurons by incubation with Accutase 
5 min 37°C, then added 3 volumes of 10% FBS (Life Technologies) in PBS and centrifuged 3 
min at 200 g. We resuspended cells in FACS buffer (10% FBS, 2 μM EDTA, 0.625 mM HEPES 
buffer (Sigma), and 10 μM ROCK inhibitor, in HBSS (Life Technologies)) at approx. 1.5-2
million cells/ml, and transferred them to 5 ml Falcon tube with cell strainer snap cap (Falcon). 
We performed FACS sorting using SH800 cell sorter (Sony Biotech), and collected TdTomato-
expressing cells into Eppendorf tubes (at least >2000 cells per sample for RNA isolation).
Quantitative polymerase chain reaction
We extracted RNA using RNAqueous micro Total RNA isolation kit (Thermo Scientific), and 
reverse transcribed the mRNA using iScriptTM cDNA Synthesis Kit (BIO-RAD, 170-8891) 
according to manufacturer’s instructions. We performed qPCR as described in article II Lund 
et al 2016.
Immunocytochemistry
We plated cells on Geltrex-coated glass coverslips until pre-fixed them by applying 4% PFA 
in 1:1 ratio into the cell culture medium for 5 min, then washed carefully with PBA and 
continued with 4% PFA for 17 min and washed 3-4 times in PBS. We permeabilized cells with 
0.05% Triton-X100 (Sigma) in PBS for 7 min, then blocked with Ultra Vision Protein Block 
(Thermo Scientific) for 10 min, and applied primary antibodies diluted in 0.1% Tween (Sigma) 
in PBS overnight at +4°C. After three washes with 0.1% Tween + PBS we applied secondary 
antibodies for 35 min-1h at room temperature. We captured immunofluoresence images by 
Zeiss Axio Imager Z1 upright epifluorescence microscope and Zen Blue (Zeiss) at 
Biomedicum Imaging Unit and processed images using ImageJ.
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Human tissue collection and immunohistrochemistry
Authors P.G., S.T. and C.A at INSERM (France) collected and processed the human fetus 
samples which where obtained with the parent’s written informed consent (Gynaecology 
Hospital Jeanne de Flandres, Lille, France). We obtained samples from 2 foetuses 10.5 weeks 
post amenorrhea, immersion-fixed in 4% paraformaldehyde in 0.1M phosphate-buffer saline 
(PBS) (pH 7.4) for 1 weeks at 4 °C, cryoprotected in 30% sucrose in PBS for 48 h, embedded 
in Tissue Tek (Miles), and frozen in liquid nitrogen, then cryosectioned samples at 18 μm on 
a CM3050 Leica Cryostat. Protocols for indirect immunofluorescence have been described in 
detail by Casoni et al 2016, and in Lund et al, 2016 and 2020.
RNA sequencing
After RNA isolation, we measured concentration, integrity and quality using Qubit Fluorometer 
and TapeStation 4200 (Agilent), and performed sequencing runs with Illumina NextSeq500
sequencer (Illumina) at FUGU (University of Helsinki) with NEBNext Ultra Directional polyA 
capture method as paired-end sequencing for read length 75 bp. We did the first run with day 
D25 FACS sorted TdTomato +/- samples (n=3), and the second run with D20 FGF8-treated 
cells, D20 w.o. FGF8 treatment, as well as D27 TdTomato + cells (n=4/group) in order to study 
differences in expression between progenitors and GnRH neurons, and the effect of FGF8 
treatment in the progenitor cells (Article III, Fig. 2 A, B). D stands for day of differentiation.
7.10 RNA sequencing data analyses
We analysed quality of raw sequencing data in FASTQ format using FASTQC (Simon An-
drews Babraham Bioinformatics), trimmed reads using Trimmomatic (Bolger, Lohse & Usadel, 
2014), and aligned the reads against GENCODE GRCh38 reference (Harrow et al., 2012)
using STAR (Dobin et al., 2013). We assessed quality of the sequencing by Qualimap (Garcia-
Alcalde et al., 2012), generated read counts from bam files by FeatureCounts (Liao, Smyth & 
Shi, 2013), and annotated with ensemble release 87 using BioMart package in R (Yates et al., 
2016, Durinck et al., 2009). We normalized and perfomed differential expression analysis us-
ing DESeq package in R (Anders, Huber, 2010). We compared the differentially expressed 
genes with absolute log-fold change over 1 and under the p-value of 0.05 (Benjamini-
Hochberg) as criteria. We performed over-representation analysis using Genetrail 2.0 (Stockel 
et al., 2016). We used Graphpad Prism 7 for drawing bar charts of differentially expressed 
genes, and Ingenuity Pathway Analys (IPA, Qiagen Inc.) for drawing gene interaction path-




8. Article I: Notch signalling during the differentiation of neural crest from 
human pluripotent stem cells
Differentiation of premigratory neural crest cells from human pluripotent stem cells
For the differentiation of NC cells from hPSC, we based our protocol on a previously reported 
method by Menendez et al. (2011). This protocol produces neural crest-like stem cells, and
was based on dual SMAD inhibition with Noggin and SB43521 for Activin A/Nodal and BMP 
signalling inhibition with simultaneous activation of the canonical Wnt pathway with BIO 
((2′Z,3′E)-6-bromoindirubin-3′-oxime). BIO is a small molecule inhibitor of GSK3 (glycogen 
synthase kinase 3). This method was first created by Menedez et al., in order to induce the
formation of ectoderm lineage, while concurrently directing cells away from a neuronal fate 
and toward the NC by using Wnt activation (Garcia-Castro, Marcelle & Bronner-Fraser, 2002, 
Patthey, Edlund & Gunhaga, 2009, Menendez et al., 2011) In our case, instead of Noggin we 
used Dorsomorphin, which is an effective small molecule inhibitor of BMP pathway (Yu, P. B. 
et al., 2008). For Wnt pathway activation, instead of BIO, we used 1-azakenpaullone as GSK3-
β inhibitor, since it has been reported to have higher selectivity towards GSK3-β (Kunick et 
al., 2004).
After culturing cells in these conditions for 10 days (hereafter referred to as D10), we detected 
an increase in NC specifier genes; PAX3, TWIST1, SLUG, MSX2, HAND2, and SOX10 by
qPCR (Article I, Fig. 1 A). Neuronal markers PAX6 and NGN2 were low after D10 (Article I, 
Fig. S1). Immunocytochemistry detected protein level expression of NC markers PAX3, 
Nestin, TWIST, SLUG and SOX10, as well as a few interspersed AP-2α-positive cells (Article 
I, Fig. 1 A). Flow cytometry showed an abundance of PAX3, SLUG, and SOX10 positive cells.
We saw a relatively low number of cells positive for AP-2α, which expressed in NC cells and 
their derivatives (Mitchell et al., 1991), and was described in human migratory NC cells
(Betters et al., 2010). This suggested that the cells were not yet in the migratory stage of 
differentiation. Furthermore, with this protocol premigratory NC cells (pNCCs) could be
maintained for up to 20 passages with the same morphology, while retaining NC marker 
expression.
In order to ensure differentiation potential, we performed clonal expansion from single cells at 
the pNCCs stage in the same medium conditions and differentiated the clones into NC 
derivatives by directed differentiation; to adipocytes, chondrocytes, osteocytes, and neurons
(Article I, Fig. 1 D-E). Neurons formed when pNCC stage cells were cultured in N2B27 without 
added factors (Article I, Fig. 1 F).
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An increase in NICD1 was detected by Western Blot, whereas no considerable change in the 
NOTCH1 receptor was seen (Article I Fig.1 G). The relative mRNA expression of the Notch 
ligand JAG1 was significantly increased, as were the Notch downstream effector genes HES1
and HES5, but this was not seen for NOTCH1, NOTCH2, and JAG2 (Article I Fig.1 H). These 
data suggest that an upregulation of Notch pathway occurs early in NC differentiation, which 
is likely caused in part by the upregulation of JAG1 expression.
Notch signalling during specification of neural crest
To investigate the role of Notch signalling during NC specification from pluripotent stem cells, 
we used small molecule inhibition of the Notch pathway by DAPT. In addition, we used shRNA 
to reduce endogenous expression of Notch ligand JAGGED1 (JAG1) in the hPSC cell pool.
By examining the mRNA expression levels of NC marker genes at D10 of the differentiation,
we found that inhibition of Notch by DAPT in two concentrations (10 μM and 20 μM) had
decreased the level of NC marker induction (Article I Fig. 2 A). Knockdown of JAG1 in hPSCs 
caused a ~60% reduction in detected JAG1 mRNA, and after 10 days of neural crest 
differentiation, the NC marker expression was, similarly, decreased (Article I Fig. 2 D).
In small molecule inhibition (DAPT) experiments, we observed an increase in NGN2 and 
NGN3 at D10 with DAPT, but not without DAPT (Article I Fig. 2 A). Similarly, in JAG1 
knockdown we observed an increase in NGN2 (Article I Fig. 2 E). The upregulation of NGN2
was also detected by RNA microarray between the DAPT-treated and non-treated pNCCs at
D10, in addition to the neuronal genes NGN1, NGN2, MASH1, NEUROD1, and PAX6 (Article 
I Fig. 3 A). Simultaneously, the NC specification markers TWIST1, PAX3, WNT3a, and HAND1
were downregulated in the dataset. These genes were also detected showing a similar pattern 
by qPCR (Article I Fig. 3 A, C). To further analyze the potential effect of Notch inhibition on 
gene networks, we performed pathway analysis of the microarray data to identify putative 
interactions between the differentially expressed genes and Notch signalling. The pathway 
analysis suggests target genes such as CER1, FOSB, FOXC1, and IGFBP4 to be regulated 
by Notch during NC specification (Article I Fig. 3 D). These data imply that active Notch 
signalling is required to sustain the expression of a large network of NC specifier genes, and 
their downstream targets.
We next asked how Notch regulates neural crest specifier genes expression. We studied the 
effect of activating Notch signalling by overexpression of NICD1 in HEK293 cells and in
hPSCs. In HEK293 cells, the transfection of the expression vector lead to an increase of HES1 
promoter and CBF1RE-luciferase activity. The successful overexpression of NICD1 in hPCS 
was confirmed by Western Blot, and pluripotency markers and morphology of the cells were
monitored before differentiation (Article I Fig. 4 A-D). NICD1 overexpression in hPCSs and
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subsequent differentiation into NC followed the same pattern in gradual upregulation of NC 
specifier genes PAX3, TWIST, SLUG, and DLX5 during the 10 first days of differentiation, but 
fold changes in relative mRNA expression were magnified (Article I Fig. 4 E). This suggests
that higher NICD1 availability in the cells during the early differentiation led to a more effective
induction of transcription factors regulating NC specification. Immunocytochemistry showed 
that TWIST1, SOX10, PAX3, and SLUG were detectable at D5, which was not the case for 
the control (non-transfected) cells (Article I Fig. 4 F). We next used chromatin 
immunoprecipitation (ChIP) to address whether NICD1 itself directly binds to 5’ promoter 
regions of NC specifier genes. ChIP showed that the recognition sequence of NICD1-CBF1 
complex was binding to DNA fragments corresponding to PAX3, DLX5, SLUG, and TWIST1
(Article I Fig. 4 G, H). This suggests that NICD acts as an activator of NC specifier genes, 
thereby promoting NC differentiation.
Notch signalling and patterning of premigratory neural crest
Notch signalling has been shown to retain cells in an undifferentiated state, whereas FGF8 
has been shown to act as a chemotactic during cardiac NC migration (Sato, A. et al., 2011).
We next asked how FGF8 treatment and Notch signalling inhibition affect the migration of 
NCCs. Using wound healing assay, we found that FGF8 treatment alone did not induce 
migration within 24 h, but migration was induced by the combination of FGF8 and DAPT
(Article I Fig. 5 A). An increase in markers that are seen in migratory cells (AP-2 a, HNK1, 
CDH6, ERBB6, ITGA4 (Tucker, G. C. et al., 1988, Betters et al., 2010) was seen by qPCR
(Article I Fig. 5 B). There was an increase in the number of AP-2α -positive cells detected with 
immunocytochemistry, and flow cytometry showed increase in the cell surface markers p75 
and HNK1 (Article I Fig. 5 C-E). This suggests that Notch inhibition combined with FGF8 can 
induce migratory NCCs.
Neuronal differentiation of pNCC occurs after Notch inhibition
After 3 days of treatment with DAPT alone, the pNCCs appeared to have neuronal morphology
and expression of neuronal markers DBH, PHOX2B, TUJ1, MASH1, NEUROD1, NGN2 were 
increased (Article I Fig. 6 A, B). Immunostainings showed positive cells for BRN3A and 
Peripherin (peripheral neurons), PHOXB1, and TUJ1 (autonomic neuron) (Article I Fig. 6 C,
D). These data suggest that inhibition of the Notch pathway, after the initial pNCC 
establishment, promotes neuronal differentiation when no further factors are added to instruct 
and support differentiation into other lineages. 
GnRH neuron differentiation was also attempted from NC culture, but no increase in GNRH1
expression was detected in these cells (data not shown).
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9. Article II: Generation of GnRH-expressing and -secreting neurons from 
human pluripotent stem cells
Differentiation of anteriorly patterned neuronal rosettes
The protocol for neuronal ectodermal induction from hPSCs was based on previously reported 
inhibition of BMP and TGF-β/Activin as a fast efficient method in monolayer culture, which 
produces anteriorly primed neuronal progenitors in the absence of caudalizing factors
(Chambers et al., 2009). After employing small molecular inhibition using Dorsomorphin
(hereafter referred to as DM) and SB431542 (hereafter referred to as SB), we acquired similar 
results, including increased mRNA expression of neuroectodermal markers SOX1 and PAX6
(Article II Fig. 1 A, B). Transcription factors PAX6, EMX2, FOXG1, DLX2, and DLX5 are 
expressed in anterior neuronal progenitors, including the olfactory neuroepithelium and rostral 
forebrain (Simeone et al., 1994, Merlo et al., 2007). We found that after D10 of DM+SB, the 
cells resemble neuroectodermal cells with an increased mRNA expression of anterior 
markers, PAX6, EMX2 and FOXG1, but not preplacodal markers SIX1 and EYA (Article II Fig.
1 B), which suggested that cells did not get patterned toward a preplacodal state. As FGF8 is 
strongly implicated in GnRH neuron development, we next treated the cells with FGF8 until 
D20, and the dish became filled with neuronal rosette structures that were positive for SOX2 
and FOXG1 antibodies. FGF8 treatment had further increased the mRNA expression of EMX2
and FOXG1, and gradually a rise in neuronal progenitor markers associated with olfactory 
neurogenesis; DLX2 and DLX5 (Article II Fig. 1 C, D). In conclusion, neuronal induction of 
hPSCs in DM+SB produces neuroectodermal cells, which form neuronal rosettes that are 
patterned to anterior neuronal fate after treatment with FGF8.
Notch inhibition accelerates neuronal differentiation of GnRH-expressing cells
After FGF8-treatment, we inhibited Notch using DAPT, which lead to an increase in GNRH1
expression after 4-8 days (Article II Fig. 2 A). We have, however, more recently observed that 
the GNRH1 mRNA peaks in most experiments approximately at D25, which is 4 days after the 
addition of DAPT (Yellapragada et al., 2019). We detected α-GnRH-positive cells by 
immunocytochemistry in bipolar cells that were also positive for neuronal-specific TUJ1 and 
α-MAP2 antibodies (Article II Fig. 2 B-D). FOXG1 transcription factor was seen also as 
cytoplasmic in D27 immunostainings, compared to mainly nuclear before the addition of 
DAPT. In accordance, the subcellular localization of FOXG1 has been reported to shift from
nuclear in proliferating, to cytoplasmic in differentiating cells (Regad et al., 2007). We detected 
cytoplasmic FOXG1 in the GnRH-positive neurons at D27, which suggests that the FOXG1-
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positive cells in the neuronal rosettes at D21 are the source of GnRH-expressing cells (Article 
II Fig. 2 E).
After DAPT addition, we measured the secretion of the GnRH decapeptide using EIA, which 
showed gradual rise with the first detectable level at D25. KCl-induced polarization increased 
secreted decapeptide medium levels by 1.97 fold (95% confidence interval, 1.62–2.31) (Article 
II Fig. 3 A-C). Furthermore, cells were observed to be highly migratory at the end of the 
differentiation. GABAA receptor stimulation has been reported to inhibit migration of GnRH 
neurons (Casoni et al., 2012). Using a gap-closure assay we studied if GABAA receptor 
agonist muscimol shows any effect on migration. We found that cell number invading the gap 
space after 50 h treatment was reduced with muscimol (n = 4; p < 0.05), suggesting that 
muscimol reduces migration.
According to these results, we concluded that GnRH-expressing and -secreting postmitotic 
neurons differentiate from anteriorly patterned, highly proliferative neuronal progenitors 
expressing FOXG1. The co-staining of with α-FOXG1 in GnRH neurons was validated in the
8th gestational week of the human foetus. FOXG1-positive cells were seen in the migratory 
mass of cells exiting from the olfactory epithelium, including the migrating GnRH-positive 
neurons (Article II Fig. 4).
10. Article III: Transcriptome of hPSC-derived GnRH neurons and FGF8-treated 
progenitor cells
Generation of GNRH1-Tdtomato reporter cell line and transcriptome characterization
We used CRISPR-Cas9 to generate a reporter hPSC line for detection of GnRH1-expressing 
neurons by fluorescent protein TdTomato. The reporter cell line was generated by knockin of 
a sequence containing 2A self-cleaving peptide followed by nuclear signal-tagged TdTomato 
at the stop-codon of the third exon of GNRH1 (Article III Fig. 1 A). As a result, cells which have 
integrated the reporter sequence by homology-directed repair, will express nuclear TdTomato 
signal as a result of GNRH1 transcription. We performed differentiation according to the 
protocol described in article II (Lund et al., 2016). GnRH and the TdTomato signal coincided 
in the same cells with high specificity, although the sensitivity was not 100% (Article III Fig. 1 
C-E). We tested the detection efficiency by performing FACS isolation of TdTomato positive 
and negative cell pools at D25 of the neuronal differentiation protocol, and performed RNA 
sequencing and differential expression analysis (Article III Fig. 1 F).  GNRH1 was significantly 
upregulated in TdTomato positive cells versus negative cells. In addition, we found 
upregulation of several KS/HH associated genes including ANOS1 (Hardelin et al., 1999), as 
well as CAMK2A, GAD1, GRIA1, GRIA2, GRIA4, and SEMA6D, whose expression has been 
previously reported in GnRH neurons of animal models (Vastagh et al., 2016, Heger et al., 
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2003, Di Giorgio et al., 2013, Spergel et al., 1999, Bailey, J. D., Centers & Jennes, 2006, Ebert 
et al., 2012). These data support the specificity of the GNRH1-Tdtomato reporter cell line, and 
provides a useful tool for GnRH neuron isolation and transcriptome analyses.
RNA sequencing reveals differences between two stages of differentiation
D20 FGF8-treated progenitors contain neuronal rosettes with anterior patterning that have not 
yet undergone terminal differentiation, nor do they contain GnRH-expressing cells (Article II, 
Fig. 1 C-D). After this stage, the cells are treated with Notch inhibitor DAPT, and GnRH 
neurons start to emerge. By D27 most of the cells have become postmitotic (Article II, Fig. 2), 
and we have not observed any considerable increase in the number of GnRH neurons after 
this point. Therefore we chose D27 as the time point to collect newly formed, postmitotic GnRH 
neurons, and we performed RNA sequencing in D20 FGF8-treated progenitor pool, and, D27 
TdTomato-positive neurons after FACS (Article III Fig. 2 A-C). Differential expression analysis 
revealed over 6000 significantly differentially expressed genes. Out of the top 50 upregulated 
genes in TdTomato positive cells, GNRH1, as well as RELN, SEMA3C, RBFOX1, PLXNA2, 
SCN2A, TAC1, GNRH1, MYT1L, BCL11B, and ISL1 were validated by qPCR, and the protein 
expression of RBFOX1, SEMA3C, DSCAM, SCN2A, PLXNA2, Substance P (TAC1), and 
PTPRN2 were validated by antibody staining (Article III Fig. 2 C, S2-5).
ISL1 is a LIM/homeodomain family transcription factor with a known role as a specifying 
transcription factor in early spinal motor neurons (Rhee et al., 2016, Cave, Sockanathan, 
2018). Using pathway analysis based on reported interactions between genes and proteins
that were represented in the top 500 upregulated genes, we observed a high number of 
interaction with ISL1 (Article III Fig. 2 G). The transcription factor ISL1 was also 
immunostained and found in the nuclei of α-GnRH-positive cells at D27, but was not detected 
in progenitor stage cells (Article III Fig. 3 A). The result was validated in a human foetus (GW 
10.5), which showed ISL1 in all GnRH-positive cells of the migratory mass, throughout the 
migratory path (Article III Fig. 3 B-G).
CHH and KS-associated genes are differentially expressed during GnRH neuron dif-
ferentiation
Out of the concurrently reported list of 37 CHH-associated genes, we found 15 within the 
differentially expressed genes between D20 FGF8-treated progenitors and D27 TdTomato-
positive cells (Article III Fig. 4 A, B). In addition of GNRH1 itself, DCC, PLXNA1, PCSK1, 
FGF17, NTN1, POLR3B were upregulated in TdTomato-positive cells.  Roles in GnRH neuron 
migration have been previously implicated in Netrin (NTN1), DCC, and Plexin-A1 (PLXNA1)
(Low et al., 2012, Bouilly et al., 2018, Schwarting et al., 2004, Marcos et al., 2017). PCSK1, 
FGF17, and POLR3B have not, to our knowledge, been reported in GnRH neurons. Out of 
52
these, FGF17 is a KS-associated gene, implying a possible role in GnRH neuron development 
(Valdes-Socin et al., 2014).
In addition, we found eight CHH-associated genes downregulated in TdTomato-positive cells, 
when compared to the D20 FGF8-treated progenitors; AXL, FEZF1, ANOS1, TAC3, TACR3, 
FGFR1, PROK2, and HESX1 (Article III, Fig 4 B). Out of these, HESX1, FGFR1, ANOS1 and 
FEZF1, are reportedly expressed during olfactory placode development (Carvalho et al., 2003, 
Hirata et al., 2006, Kotan et al., 2014). PROK2 and AXL1 are reportedly associated with the 
GnRH neuron migratory route (Pitteloud et al., 2007, Allen et al., 2002, Pierce et al., 2008),
and TAC3 and TACR3 are expressed in hypothalamic Kisspeptin/Neurokinin B/Dynorphin-
expressing neurons (Navarro, Tena-Sempere, 2011). This data shows that some of the CHH-
associated genes are indeed expressed during GnRH neurons differentiation, and that the 
hPSC-based model for GnRH neuron development is a promising tool that can be utilized in 
the investigation of the disease mechanisms.
Overlapping genes in FGF8-treated progenitors and TdTomato-positive neurons
In addition to changes in transcriptome between progenitor and terminally differentiated 
neuron, we were interested in finding genes that are common and putatively specific 
progenitor markers for GnRH neurons. Since the FGF8-containing conditions produce GnRH 
neurons but non-treated conditions do not (article II), we compared FGF8-treated progenitors 
and TdTomato-positive neurons to non-treated cells from the same protocol at day 20. We 
asked; which genes are upregulated in both FGF8-treated progenitors and TdTomato-positive 
neurons, compared to “unpatterned” neuronal cells? We found, perhaps surprisingly, 37 genes 
with these criteria (Article III, Fig. 5 C), which suggests that the differences may be larger than 
the similarities and most genes are dependent on the stage (or timing) of neuronal maturation. 
Out of these, the most highly upregulated gene in TdTomato-positive cells was DUSP4, which 
has a role in negative feedback loop in FGF signalling pathway by ERK dephosphorylation 
that reportedly increases concomitantly with Fgf stimulation (Peng, Zhou & Wu, 2010, van 
Boxtel et al., 2018). Interestingly, DUSP6 has been implicated as CHH candidate gene, which 
shows association with FGF8-expression in vivo, in the so-called ‘FGF8 synexpression group’
(Miraoui et al., 2013). The FGF8 synexpression group, gathered from the literature by Miraoui 
and colleagues, is a cluster of genes which shows spatiotemporally similar expression patterns 
to FGF8 across several organisms, and modulate signalling of FGF8 through FGFR1 as 
enhancers or inhibitors. The synexpression group also includes another gene in our list, 
FGF17. Also, one of the upregulated genes in this analysis was the previously mentioned 
FOXG1. Together, these data supports that FOXG1, and DUSP4 together with FGF17,
upregulated by FGF8, are interesting candidates for important roles in GnRH neuron 
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specification and differentiation. Lastly, previously reported genes with direct or indirect 
interaction to GnRH; TLE4, SOX11, MEF2C, GAL, GAD1, CPE, and GPR173 were 
upregulated in TdTomato-expressing cells only (Article III, Fig. 5 E). Interestingly, SOX11 has 
been implicated in the activation of GNRH1 transcription in murine cells (Kim, H. D. et al., 
2011).
11. Previously unpublished results
During the protocol planning of GnRH neuron differentiation, we considered the possibility that 
a preplacodal ectodermal stage, including upregulation of placodal markers such as SIX1 and 
EYA1, would be required prior to neuroectoderm establishment for the correct (precursor) cell 
fate to be generated. For this purpose, we tested two different options. 1) outlining a new 
protocol based on developmental signals implicated during establishment of the cranial 
placodes, and 2) testing a published protocol for the generation of SIX1-positive cells (Leung, 
Alan W., Kent Morest & Li, 2013), and continuing differentiation from these progenitors. 
The olfactory placode protocol
Since BMP and Wnt inhibitors are present during preplacodal ectoderm fate specification, and 
FGF8 is expressed in the developing olfactory placode, we hypothesized that a combination 
of BMP and Wnt inhibitors and FGF8 treatment could be needed for olfactory placode 
differentiation. We started differentiation using these factors in N2B27 medium, passaging 
cells weekly and acquiring samples on D7, 14, and 21, to detect expression of olfactory 
placode-associated genes (Figure 4 A). We found a modest increase of the preplacodal 
markers SIX1 and EYA1, and the OP-associated DLX5, and FOXG1 expression progressively 
increased until D21 (Figure 4 B). Immunocytochemistry at D21 showed PAX6-reactivity in 
most of the cells, and EYA1, SIX1 and DLX5 in a subset of cells (Figure 4 C). However, the 
reactivity for SIX1 and DLX5 did not seem to co-localize to the same cells, which suggests the 
presence of two developmentally distinct populations of cells, either by subtype (neuron vs. 
non-neuron) or different developmental stage. The neuron progenitor marker ASCL1 (‘Mash1’ 
in Figure 4 C) and neuronal marker TUJ1 were also detected, which suggests that neuronal 
differentiation had occurred. On D21 onward, we applied DAPT to inhibit the Notch pathway 
and accelerate neuronal differentiation, and cultured cells until D28. GNRH1 expression 
remained low until D21, but was upregulated at D28. FOXG1 expression showed a peak at 
D21, and was slightly reduced after Notch inhibition on D28, while the expression of EMX2,





Figure 4. Protocol for differentiation of GnRH neurons based on the ‘olfactory placode differentiation’ 
protocol. A) Protocol timeline and added factors during differentiation. D stands for days of differentiation. Cells 
were passaged on D7, 14, and 21. DAPT was added on D22. B) Relative expression to D0 hPSCs of the placodal 
genes EYA1, SIX1, and OP genes DLX5, FOXG1 during protocol detected by qPCR. C) Immunocytochemistry at 
D21 of the differentiation. D) Relative expression of GNRH1, FOXG1, and EMX2 during differentiation detected by 
qPCR. E) Immunocytochemistry at D28 of differentiation, scale bar indicates 100 μm. In panels B and D, n = 4, 
error bars indicate standard error of the mean. Images in C captured using EVOS FL inverted epifluorescence 
wide-field microscope (ThermoFisher), and in E using Axio Imager Z1 upright epifluorescence microscope (Zeiss) 
(Lund 2014, unpublished data). 
 
 
The cell morphology was heterogeneous. GnRH-immunopositive cells were detected in 
clusters that were positive for TUJ1, DCC and the peripheral neuron marker Peripherin (Figure 
4 E). This suggests that only a subset of cells were able to undergo full neuronal differentiation, 
and albeit GnRH-expressing neurons were successfully obtained, the overall efficiency was 
relatively low. However, we saw that FOXG1 upregulation preceded GnRH neuron 
differentiation, and we continued our work with the hypothesis that FOXG1-expression 
provided a marker for successful differentiation toward GnRH neurons. 
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 Preplacodal ectoderm protocol  
The preplacodal ectoderm cell differentiation was based on a report published by Leung and 
colleugues (Leung, Alan W., Kent Morest & Li, 2013), where a serum-free medium recipe 
containing N2 and B27 supplements (without addition of growth factors or Neurobasal media) 
induced PPE in roughly 6 days. This protocol reported the highest expression of SIX1 and 
EYA2 in the absence of extrinsic noggin or BMP, followed by late inhibition of BMP on D6-9, 
which induced expression of anterior placode markers PAX6 and PAX3 (Leung, Alan W., Kent 
Morest & Li, 2013). We repeated this protocol and continued with FGF8 and DAPT treatment 
from D9-28. SIX1, EYA1, PAX6, and AP2 were initially induced but no considerable rise in 
GNRH1 expression was observed (Figure 5). This result suggested that differentiation through 
a PPE-like stage with upregulation of SIX1 and EYA1 was not an effective strategy for GnRH 
neuron differentiation in vitro. Possibly, the SIX1- and EYA1-positive cells represented a 
population that had already been patterned toward other types of cells, and were therefore not 




Figure 5. Attempt to differentiate GnRH neurons via preplacodal ectodermal stage.  
A) Preplacodal ectoderm differentiation at D9, containing SIX1 and AP-2α immunopositive cells. Imaged using 
EVOS FL inverted epifluorescence wide-field microscope (ThermoFisher). Scale bar indicates 200 μm. B) Relative 
expression to D0 hPSCs of EYA1, SIX1, AP-2α and PAX6 during differentiation performed by qPCR. D stands for 
days of differentiation. C) Relative expression of GNRH1 during differentiation. Experiments were repeated three 




 Expression of FGF13 in neuronal progenitors and GnRH-expressing neurons 
After the RNA sequencing described in article III, we found that FGF13 was one of the genes 
upregulated in both the FGF8-treated progenitor pool and TdTomato-expressing GnRH 
neurons. We performed immunocytochemistry for FGF13 at both stages. In the progenitors at 
D21, FGF13 was localized inside neuronal rosette cells, polarized apically toward the luminal 
center of the rosette (Figure 6 A). In GnRH-immunopositive neurons at D27, FGF13 was 








Figure 6. FGF13 immunocytochemistry in FGF8-treated neuronal rosettes, and GnRH-positive neurons, 
derived from human pluripotent stem cells. A) FGF13 and MAP2 in neuronal rosettes at D21 of the GnRH 
neuron differentiation protocol presented in article II (Lund et al., 2016), and B) FGF13 and GnRH at D27 of 
differentiation. Imaged using Axio Imager Z1 upright epifluorescence microscope (Zeiss). Scale bars indicate 50 







12. Neural crest differentiation in vitro
Neural crest cells are a transient stem cell-like population of cells with extraordinary potential 
for migration and developmental plasticity. The transient nature of the population in vivo has 
prompted research to include in vitro modelling of neural crest multipotency and differentiation. 
Our first aim was to develop an effective and reproducible protocol for differentiation of neural 
crest and their derivatives, in order to, in the future, study certain cell types affected by a
disease. Before the publication of our manuscript, a few articles had recently presented 
important data on directed differentiation of neural crest-like cells from hPSCs (Menendez et 
al., 2011, Mica et al., 2013). These authors had already established the effectiveness of BMP 
/Nodal/ TGF-β pathways’ modulation and activation of Wnt signalling to induce differentiation 
through activating a combination of critical transcription factors marking NC specification, 
including AP-2α, PAX3, SNAIL, and SOX10. We found that this was achieved using 
Dorsomorphin, a small molecule inhibitor of ALK2, 4, 6, which blocks BMP-mediated SMAD 
1/5/8 phosphorylation, and 1-azakenpaullone, small molecule inhibitor of GSK3-β, efficiently 
activating canonical Wnt signalling. This proved to be a simple way to mimic NC differentiation 
in vitro, resulting in a population of approximately 70-80% efficiency in conditions that support 
retainment of their developmental potential for up to 20 passages. Because of the ability to 
induce migratory behaviour and directed differentiation of these cells, we considered the cells 
as an early stage cell type of premigratory NC-like cells (pNCCs). More recently, the 
generation of non-adherent cultures of human premigratory NC-like cells was reported
(Kerosuo et al., 2015). Kerosuo and colleagues found that a non-adhesive substrate favoured
multipotency and thereby performed neurosphere-like culture condition to generate 
crestosphere cultures of NC-like stem cells with high expression of premigratory NC markers 
PAX7, FOXD3, and SOX10, and moderate expression of stem cell marker SOX2, mimicking 
avian premigratory NC in vitro. In these conditions, cells retain multipotency and self-renewal 
capacity up to 7 weeks, (in vivo estimate is around 5 hours). Proliferation gradually decreased 
during this time, resulting in loss of transit-amplifying progenitors at the end of 7 weeks of 
culture. In vivo, NC formation is achieved in the context of neural plate and epidermal 
induction. The 3D-organization reported by Kerosuo et al. 2015 possibly mimics more closely 
the epithelial organization and resembles the in vivo-like premigratory stage of development.
However, if looking to study specific derivative cell types of NC for instance for disease 
modelling purpose, a more homogeneous monolayer can prove to be a more efficient, and 
pragmatic approach. For instance, during our differentiation protocol from hPSCs in vitro, the 
emergence of epidermis is purposely blocked by BMP inhibition. Thus, the interaction between 
these tissues cannot be observed, but it is easier to detect and study NCCs, specifically. That 
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said, NC cells being a highly plastic kind of progenitor cell type, the definitive NC specification 
can be difficult to define, and the combination of markers used to define premigratory and 
migratory neural crest cells might currently be too limited. For example, during in vitro culture 
the NC-progenitor cells can retain multipotency for long periods when provided with right 
conditions. How do the culture conditions affect the transition between premigratory,
migratory, and postmigratory NC cell types generated in the dish, when proliferation is 
sustained? At what stage does priming to downstream lineages occur, and is cell potential 
biased by the culture method? Very recently, new methods in single-cell RNA sequencing 
have recovered new insight into the gene expression associated with that transient state of 
premigratory neural crest cells, and cell fate decision from neural tube stages to migration and 
differentiation (Soldatov et al., 2019). The study was performed in mice neural crest by 
combined linage tracing and functional perturbations to study the effect of transcriptional 
changes on cell fate decisions. Results indicated that cell fate choices take place as a 
sequence of binary decisions, which are gradually acquired. The first binary decision to arise 
is between neuro-glial and mesenchymal cell fates at early NC migratory stages, followed by 
autonomic and mesenchymal lineages. Transcription associated with the cell decision is 
sequential, and occurs through initial co-activation, gradual biasing, and commitment phases. 
In the premigratory state, early genes of competing cell fate programs become co-activated in 
the same cell. Gradually, cells come to a bifurcation point, where activation and repression 
further increase and lead to a cell fate bias. Commitment occurs by activation of mutually 
exclusive cell fate genes. In cranial neural crest, transcriptional changes suggesting cell fate 
bias for neuronal vs. mesenchymal fate were present already at the delamination phase 
(Soldatov et al., 2019). Therefore, it is possible that long-term culture of NC cells in vitro affects 
multipotency by gradual enrichment of “biased” cells in these cultures. Single-cell analyses 
will most likely be a useful tool for developing effective differentiation protocols for specific cell 
lineages in vitro.
13. Notch signalling and neural crest
Since Notch signalling modulation had been previously utilized successfully in neuronal 
differentiation protocols to affect differentiation and maturation of neurons, we were interested 
in the effect of Notch during NC cell differentiation. During neural crest specification in vivo,
Notch signalling has been reported to contribute in the establishment of the border between 
neural and non-neural territories in the neural plate border region. In the Xenopus embyo, the
activation of Notch pathway leads to neural crest territory expansion, and the blocking of Notch 
signalling leads to inhibition of NC marker expression (Glavic et al., 2004). Since it is known 
that BMP signalling regulates NC and the overlying epidermis expresses BMP during NC 
59
induction, Notch pathway was proposed to regulate the level of BMP activation. Specifically, 
by Notch ligand Delta 1 maintaining BMP4 expression in the neighbouring epidermal tissue 
(Endo, Osumi & Wakamatsu, 2002, Glavic et al., 2004). The homeoprotein transcription factor 
Xiro is expressed in the neural plate border in Xenopus embryos during neural crest 
specification (Mayor, Aybar, 2001). Glavic and colleagues observed that the activation of Xiro1
and Notch repressed the expression of BMP4 and the Notch effector Hairy2 during neural 
crest specification, which led to the hypothesis that Xiro1 lies upstream of Delta in the
regulation of BMP4 expression at the border between the NC and the epidermis. This way, 
Notch pathway restricts the activation of NC specifying factors outside the prospective NC
territory, as well as induces, or re-enforces appropriate transcription factor expression within 
the NC territory. Our results are in agreement with these findings and suggest that Notch 
activation is important for proper neural crest specification. This is seen by the effect of 
blocking of Notch during the first 10 days of the protocol, which inhibits formation of NC cells 
by not allowing for proper activation of neural crest specifier genes. Together, this might 
suggest that regulation of NC development by the Notch pathway could act by 1) expansion 
of NC progenitors in the NC territory, or 2) allowing for progression of differentiation from 
neural plate border-like ectodermal cells, to neural crest definitive specification, or perhaps 
both.
In our results, overexpression of NICD resulted in increased expression of NC specifiers, and 
accelerated NCC specification by several days. Supporting evidence in chick exists, stating 
that an appropriate level of Notch activation leads to NC induction (and EMT) (Gouti, Briscoe 
& Gavalas, 2011). We found that applying Notch signalling inhibition after pNCC specification 
initiated cell migration, and accelerated differentiation towards neuronal derivatives. This kind 
of role for Notch signalling during murine neural crest differentiation has been studied using
Cre-mediated conditional knockout and overexpression of Notch in NC cells (Mead, Yutzey, 
2012), which revealed that Notch affected cell migration, proliferation, differentiation, and cell 
fate choices of NC derivatives in cranial, cardiac, and trunk NC. Gain of Notch signalling
resulted in increased proliferation and deficient migration of NCCs.
Because of a broad array of derivatives, and the complexity of NC cells, in order to reveal the
mechanisms of neurocristopathy-associated genes and their developmental processes,
further research endeavours focusing more closely on the effect of Notch pathway (and other 
signalling pathways) in cell fate decision would be highly useful. Such an example that would 
benefit the field of puberty research and GnRH biology are the ontogeny and differentiation of 
NC-derived olfactory ensheating cells, which have been affirmed to support the development
of GnRH neurons (Barraud et al., 2013, Geller et al., 2017).
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14.Neural crest contribution to GnRH neuron cell population
NC lineage tracing experiments in mice have presented evidence that, perhaps surprisingly, 
suggest contribution of neural crest cells to the olfactory placode (Forni et al., 2011), which 
was not in accordance with the contemporary dogma of GnRH neuron origin. This led us to 
hypothesize that in vitro generation of GnRH neurons might be also possible from neural crest 
progenitor cells, but these results could not be obtained at the time. Neural crest contribution 
has been since disputed in other species, but the question of GnRH neuron ontogeny has not 
to this day been fully resolved. The lack of known progenitor markers specific for GnRH 
neurons causes considerable difficulty. To this day, no reports exist where hPSC-derived NC 
could give rise to GnRH neurons, which could support their NC origin, even though the amount
of research on NC differentiation has increased rapidly. Characterization of human foetal 
GnRH neurons has not been able to identify any SOX10 expression in early developing GnRH 
neurons in the nose (Casoni et al., 2016), which argues against the hypothesis of dual origin 
(the neural crest and olfactory placode) of GnRH neurons.
15.Olfactory placode and GnRH neuron specification
Less efforts had been made at the time when we started this work to generate cranial placode 
cells and derivatives from human pluripotent stem cells. The first protocols for placode 
differentiation were published in 2013 (Leung, Alan W., Kent Morest & Li, 2013, Dincer et al., 
2013). These protocols produced placode-derived trigeminal ganglia cells, lens fibres, anterior 
pituitary hormone-producing cells (Dincer et al., 2013), lens placode, and oral ectoderm 
(pituitary precursor cells) (Leung, Alan W., Kent Morest & Li, 2013). Specific differentiation into 
olfactory placode or differentiated cell types of the main olfactory system have not been 
reported so far. The difficulty in defining successfulness of OP patterning in these protocols 
may be due to the fact that most markers that represent early OP and OE in the frontonasal 
area are also found in the forebrain, such as DLX2, DLX5, PAX6, and FOXG1 (Duggan et al., 
2008, Merlo et al., 2007, Simeone et al., 1994).
Six1 and Eya1 are the only markers that are specific for placodal ectoderm and not expressed 
in the neural tube and neural crest. The Six and Eya family genes are, however, thought to be 
required for development of all the cranial placodes (Schlosser, 2006). Thus, OP being closely 
associated to the anterior-most neural tube might be an important clue into finding differences 
specific between the distinct placodes. Defining such differences at early time points in 
development would be one of the possible prerequisites to finding out the true origin of GnRH 
neurons. A recent report in zebrafish traced back the progenitors of GnRH-expressing neurons 
to cells migrating out of the most anterior part of the PPE at the neural plate border (Aguillon 
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et al., 2018). The same population gave rise also to olfactory microvillus neurons, and 
considerable overlap to adenohypophysis progenitors was observed. The latter has been 
described in zebrafish previously (Toro, Varga, 2007), but in the chick, these progenitors were 
described as non-overlapping distinct populations (Sabado et al., 2012). Overlap of this sort 
has so far not been described in mice. With development of better tools for genetic tracing, it 
would be interesting to study at which point the definitive specification of separate olfactory 
and adenohypophyseal placodal progenitors occur, how the PPE cells adopt differing fate 
based on position and patterning signals, and how this is translated during in vitro specification 
of GnRH neurons in our differentiation protocol.
16.Differentiation of GnRH-expressing neurons 
High confluency monolayer culture promotes neuroectoderm induction from hPSC (Chambers 
et al., 2009) and we observed that this method, beginning from over 90% confluent dishes, 
produced more homogeneous neuronal cultures than lower cell densities. Already at D10 of 
differentiation, neuronal rosettes started to appear. Neuronal rosettes are radial structures that 
form spontaneously during neuronal induction in vitro, initiated by cell polarisation and 
asymmetric distribution of proteins, such as tight junction markers ZO-1 and N-cadherin,
leading to formation of a central lumen toward which cells are attaching their apical 
membranes, connected by adherence junctions (Elkabetz et al., 2008). Elkabetz and 
colleagues first describe the rosette stage cells to have broad differentiation potential. 
Expression of high FOXG1 was observed in spontaneously forming rosettes, which suggests
that early rosettes adopt an anterior CNS patterning by default but can be patterned to caudal 
and ventral fates by the addition of extrinsic factors such as SHH and Wnt.
We also observed FOXG1 upregulation already at D10, which was further upregulated during
FGF8 treatment until D20. FGF8 has been shown to promote neurogenesis and transient self-
renewal of neuronal rosettes derived from mouse ES cells (Sterneckert et al., 2010).
DAPT treatment has been found to disrupt the rosette morphology and induce neural 
differentiation (Elkabetz et al., 2008). Another study found that Presenilin2, a component of 
the gamma-secretase complex, is distributed apically in the rosettes, co-localizing to 
adherence junctions at the central lumen (Banda et al., 2015). This may be related to high 
Notch activity in rosette-stage cells, by gamma-secretase cleavage of Notch to release NICD 
in the cells.
Our observation during the protocol is that FGF8 treatment results in a higher number of cells
number at D20, increases the overall number of rosettes, and keeps cells in the rosette stage 
(clear rosette organization) for a longer time compared to FGF8 non-treated controls. FOXG1 
expression is high, whereas NKX2.1, expressed in ventral forebrain and diencephalon, is kept 
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low. Other hypothalamic neuroendocrine cell types, such as POMC-expressing neurons can 
be generated by SHH treatment during differentiation. This supresses FOXG1 and promotes 
ventralization by NKX2.1 expression (Merkle et al., 2015), but this protocol does not produce 
GnRH neurons. Therefore, these data suggest that FGF8 promotes survival of immature, but 
anteriorly patterned, neuronal progenitor cells in vitro, as long as the rosette structure is 
retained. This may be in part regulated by high Notch activity. Furthermore, our data suggest 
that these FOXG1-expressing progenitor cells give rise to GnRH-expressing neurons, 
supported by retained cytoplasmic FOXG1 in early postmitotic GnRH-positive cells, and co-
expression also in human foetal GnRH neurons.
17.Transcriptomic analysis during in vitro differentiation revealed a high 
number of genes upregulated in newly emerged GnRH- expressing neurons 
The GnRH neuron early transcriptome is an important step towards understanding human 
puberty development and rare diseases where GnRH neuron development is disrupted. Our 
transcriptome analyses gave a large amount of information that could generate lots of 
interesting ideas and hypotheses to discuss. The data was therefore somewhat challenging
to summarize. We chose to describe the transcriptomic data as an independent entity to bring 
forward and support the development in the field using previously unreported methods, and in 
hope that hPSC modelling might become more readily used in the future for dissecting 
molecular mechanisms of GnRH neuron biology, together with animal models. Many new 
interesting hypotheses can be drawn. The following sections briefly discuss our findings and 
their potential implications.
Major differences between FGF8-treated and non-treated neuronal progenitor cells
The sample group used for differential expression analyses are summarized in article III, Fig. 
2 A. Differential expression analysis revealed 511 upregulated and 275 downregulated genes 
in the FGF8 treated versus non-treated cells at D20. Over-representation analysis of genes 
(genetrail) upregulated or downregulated showed that: 1) Cell component gene groups 
showed some differences related to cell shape and attachment. For instance, in FGF8-treated 
cells, the enriched terms included contractile fibers, microtubule associated complex, 
extracellular matrix component, apical junction complex, cell cell contact zone, and apical 
plasma membrane. These terms are well in line with the highly abundant rosette structures in 
FGF8-treated culture. In the non-treated cultures, the rosettes do appear after D10, but are 
generally larger, and fewer in number. The enriched cellular components included more terms 
associated with neuronal differentiation, such as postsynaptic membrane, axon terminus, 
neuron projection terminus, axon growth cone, and synaptic membrane. This supports the 
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previously discussed role of FGF8 in promoting the rosette organization of the cells, which 
keeps them in undifferentiated state. 2) In the FGF8-treated cells, KEGG pathways showed 
enrichment of endocrine cell type-related terms, such as insulin secretion, pancreatic 
secretion, thyroid hormone synthesis, and endocrine and other factor-regulated calcium 
reabsorption. It is interesting to speculate that this could be related to the development of 
GnRH neuron precursor cells. 3) Enriched KEGG pathway terms in FGF8-treated cells also 
included the signalling pathways Rap1 signalling, HIF-1 signalling, Pi3K-Akt signalling, and 
MAPK signalling pathway, whereas non-treated cells showed enrichment of Hippo signalling 
pathway.
Intracellular signalling pathways HIF-1, Pi3K-Akt, and MAPK pathway are associated with 
many processes including, proliferation, differentiation, and survival (Xie, Lowry, 2018, Yu, J. 
S., Cui, 2016, Sun et al., 2015), and Rap1 is implicated in cell adhesion (Kooistra, Dube & 
Bos, 2007), while the Hippo pathway is known for its role in limiting organ size by modulating 
cell proliferation (Ehmer, Sage, 2016).
Major differences between FGF8-treated progenitors and TdTomato-positive neurons
A long list of differentially expressed genes (over 6000) was found between these two sample 
groups, suggesting that the differentiation and specialization that has occurred between the 
rosette-stage progenitor and postmitotic GnRH-expressing cell is extensive.
Over-representation analysis showed that the progenitor-enriched pathways where high in 
terms related to proliferation, and, for instance, the Notch pathway was indeed represented in 
the top 50 most (D27 Tdt+ versus D20FGF8) downregulated genes. Interestingly, the gene 
with the highest fold change score was DLK1. DLK1 (Delta-like non-canonical Notch ligand 1)
DLK1 has been described in patient with paternally inherited deletion associated with familial 
central precocious puberty (Dauber et al., 2017) and has been suggested as potential 
regulator of puberty timing (Day et al., 2017). DLK1 is a transmembrane protein with an 
extracellular domain containing six epidermal growth factor repeats. DLK1 has sequence 
homology with Delta, but lacks the DSL-motif that can activate Notch. DLK1 marks embryonic 
tissues and immature cells, implicated in tissue growth and development and regenerative 
potential (Floridon et al., 2000). The exact function is not known. DLK1 has been implicated 
in Notch inhibition, but has also been found highly expressed in several embryonic tissues 
where Notch signalling is high (Falix et al., 2012). DLK1 downregulation is required for the
initiation of final maturation is some tissues, including pancreatic β-cells. The embryonic and 
foetal expressions of DLK1 in several endocrine tissues have suggested a role for DLK-1 in 
maturation of endocrine/neuroendocrine cells. DLK1 expression is restricted to certain
populations of cells during lung and pancreas morphogenesis, which could imply a role of 
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grading of Notch activity (or other factors) to regulate cell fate (Floridon et al., 2000).
Furthermore, DLK1 has been implicated in regulation of other pathways, such as FGF 
(Miyaoka et al., 2010). DLK1 expression is lost in adrenal capsule of FgfrIIIb knockout mice, 
which exhibit hypoplastic adrenals with impaired steroidogenic differentiation (Guasti et al., 
2013).
Perhaps one of the most interesting findings of upregulated genes in TdTomato-positive cells 
was ISL1, which was immunostained also in human foetal GnRH neurons. ISL1 is a LIM factor 
that forms heterodimers with other LIM factor family transcription factors, such as LHX genes, 
and promotes differentiation of specialized cell types including motor neurons and forebrain 
cholinergic neurons by regulating the expression of cell type specific genes (Cho et al., 2014).
With interest to predict interaction partners of ISL1 in our protocol, we looked at the gene 
interaction network represented in the data from this analysis. The network contained 13 
previously reported protein-protein interactions, including the LIM-domain containing genes 
LMO2, LDB2, and AJUBA. Since LMO2 was upregulated and LDB2 and AJUBA were
downregulated, it would be interesting to study whether ISL1 interaction between them is 
involved in regulation of terminal differentiation of GnRH neurons.
Kallmann Syndome and CHH genes represented in the data
In the same differential expression analysis described in the previous section, the D20FGF8-
treated vs GnRH neurons, we found the highest number of KS and CHH genes (Article III, Fig 
4A). Seven genes upregulated in TdTomato-positive cells, and eight in the progenitor pool. 
The list contained genes related to FGF signalling: FGFR1, ANOS1, and FGF17 (Miraoui et 
al., 2013), neuropeptide regulation; TAC3 and TACR3 (Francou et al., 2011, Yang et al., 
2012), and migration-associated genes FEZF1, DCC, PLXNA1, and NTN1 (Kotan et al., 2014, 
Bouilly et al., 2018, Marcos et al., 2017). All 15 genes are interesting candidates to study
further their involvement in GnRH neuron specification and differentiation. It is possible that 
genes needed for specification have been upregulated earlier, but future methods such as 
single-cell RNA sequencing at different stages of differentiation might be helpful to find out 
such associations.
FGF8-treated progenitors and TdTomato positive neurons, overlapping gene expres-
sion
We used the FGF8 non-treated D20 neuronal cultures as controls in comparison with both 
D20FGF8 and TdTomato, to find possible overlaps in the upregulated genes. The question 
would be whether there is any putative markers that become expressed already before 
terminal differentiation in FGF8-treated cells that can still be detected in GnRH neurons, 
similar to FOXG1 shown in article II. The overlap was quite moderate, with 37 genes (Article 
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III, Fig 5 A), however not surprising, as the samples did show considerable divergence in the 
previously described analyses. Among these 37 was indeed FOXG1.
DUSP4 was the gene with highest ranked expression in TdTomato positive cells at D27, which 
was also found upregulated in the progenitor stage cells (Article III, Fig 5 A). DUSP4 has been 
implicated in regulation of neuronal differentiation and calcium homeostasis by modulating 
ERK1/2 phosphorylation (Kim, S. Y. et al., 2015).
We tested some of these markers using antibody staining, and found that FGF13 was, similarly 
to FOXG1, stained both in the rosette stage progenitors and in the postmitotic GnRH neurons 
(Figure 6). Interestingly, FGF13 has been recently implicated as a KS candidate gene 
(Quaynor et al., 2016), and mRNA expression was reported in mouse GnRH neurons in a 
recent study (Burger et al., 2018). FGF13 is an intracellular non-secretory protein that 
functions as a microtubule-stabilizing protein during cerebral cortex development (Wu et al., 
2012). Our immunostainings in the previously unpublished data (Figure 5) indeed showed that 
FGF13 is localized to the apical side of the rosette cells, clearly toward the luminal center of 
the rosettes, and more broadly and predominantly one-sidedly in the delaminating neuronal 
cells just outside the rosettes. An additional observation was that at D27 there are some 
GnRH-negative cells with shorter projections, which have more local expression of FGF13 
next to the nucleus, and appear to be shorter in shape. These may be less mature cells that 
have not yet differentiated to neurons, or represent another cell type with distinct morphology.
18.Conclusions and future perspective
GnRH neuron differentiation from human pluripotent stem cells in vitro is efficiently and in a 
consistently repeatable manner achieved by dual SMAD inhibition, FGF8 treatment and
subsequent Notch inhibition. The protocol for in vitro differentiation is a promising tool for 
studying molecular mechanisms of KS and CHH-associated genes in the future. The 
transcriptomic characterization has brought better understanding in how the differentiation 
might be regulated, and basis for many new hypotheses to help approach the questions that 
remain about GnRH neuron specification and developmental specialization.
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